<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Drugs for the treatment of nausea and vomiting in adults in the emergency department setting - Furyk, JS - 2015 | Cochrane Library</title> <meta content="Drugs for the treatment of nausea and vomiting in adults in the emergency department setting - Furyk, JS - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010106.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Drugs for the treatment of nausea and vomiting in adults in the emergency department setting - Furyk, JS - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010106.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010106.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Drugs for the treatment of nausea and vomiting in adults in the emergency department setting" name="citation_title"/> <meta content="Jeremy S Furyk" name="citation_author"/> <meta content="jsfuryk@hotmail.com" name="citation_author_email"/> <meta content="Robert A Meek" name="citation_author"/> <meta content="Diana Egerton‐Warburton" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="9" name="citation_issue"/> <meta content="10.1002/14651858.CD010106.pub2" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/09/28" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010106.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010106.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010106.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Emergency Service, Hospital; Antiemetics [*therapeutic use]; Droperidol [therapeutic use]; Metoclopramide [therapeutic use]; Nausea [*drug therapy]; Ondansetron [therapeutic use]; Prochlorperazine [therapeutic use]; Promethazine [therapeutic use]; Randomized Controlled Trials as Topic; Visual Analog Scale; Vomiting [*drug therapy]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010106.pub2&amp;doi=10.1002/14651858.CD010106.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010106.pub2&amp;doi=10.1002/14651858.CD010106.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010106.pub2&amp;doi=10.1002/14651858.CD010106.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010106.pub2&amp;doi=10.1002/14651858.CD010106.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010106.pub2&amp;doi=10.1002/14651858.CD010106.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010106.pub2&amp;doi=10.1002/14651858.CD010106.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010106.pub2&amp;doi=10.1002/14651858.CD010106.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010106.pub2&amp;doi=10.1002/14651858.CD010106.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010106.pub2&amp;doi=10.1002/14651858.CD010106.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010106.pub2&amp;doi=10.1002/14651858.CD010106.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010106.pub2&amp;doi=10.1002/14651858.CD010106.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010106.pub2&amp;doi=10.1002/14651858.CD010106.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010106.pub2&amp;doi=10.1002/14651858.CD010106.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010106.pub2&amp;doi=10.1002/14651858.CD010106.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010106.pub2&amp;doi=10.1002/14651858.CD010106.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010106.pub2&amp;doi=10.1002/14651858.CD010106.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010106.pub2&amp;doi=10.1002/14651858.CD010106.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010106.pub2&amp;doi=10.1002/14651858.CD010106.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010106.pub2&amp;doi=10.1002/14651858.CD010106.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010106.pub2&amp;doi=10.1002/14651858.CD010106.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010106.pub2&amp;doi=10.1002/14651858.CD010106.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010106.pub2&amp;doi=10.1002/14651858.CD010106.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010106.pub2&amp;doi=10.1002/14651858.CD010106.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="tkZQC4GK";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010106\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010106\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010106\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010106\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","pt","hr","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010106.pub2",title:"Drugs for the treatment of nausea and vomiting in adults in the emergency department setting",firstPublishedDate:"Sep 28, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Emergency and Critical Care Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=tkZQC4GK&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010106.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010106.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010106.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010106.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010106.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010106.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010106.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010106.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010106.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010106.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>11837 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010106.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010106.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010106.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010106.pub2/full#CD010106-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010106.pub2/full#CD010106-sec-0144"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010106.pub2/full#CD010106-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010106.pub2/full#CD010106-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010106.pub2/full#CD010106-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010106.pub2/full#CD010106-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010106.pub2/full#CD010106-sec-0060"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010106.pub2/full#CD010106-sec-0138"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010106.pub2/appendices#CD010106-sec-0149"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/table_n/CD010106StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/table_n/CD010106StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010106.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010106.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010106.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010106.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010106.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010106.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Drugs for the treatment of nausea and vomiting in adults in the emergency department setting </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010106.pub2/information#CD010106-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Jeremy S Furyk</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010106.pub2/information#CD010106-cr-0003">Robert A Meek</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010106.pub2/information#CD010106-cr-0004">Diana Egerton‐Warburton</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/information/en#CD010106-sec-0157">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 28 September 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010106.pub2">https://doi.org/10.1002/14651858.CD010106.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010106-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010106-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010106-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010106-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010106-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/pt#CD010106-abs-0002">Português</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010106-abs-0001" lang="en"> <section id="CD010106-sec-0001"> <h3 class="title" id="CD010106-sec-0001">Background</h3> <p>Nausea and vomiting is a common and distressing presenting complaint in emergency departments (ED). The aetiology of nausea and vomiting in EDs is diverse and drugs are commonly prescribed. There is currently no consensus as to the optimum drug treatment of nausea and vomiting in the adult ED setting. </p> </section> <section id="CD010106-sec-0002"> <h3 class="title" id="CD010106-sec-0002">Objectives</h3> <p>To provide evidence of the efficacy and safety of antiemetic medications in the management of nausea and vomiting in the adult ED setting. </p> </section> <section id="CD010106-sec-0003"> <h3 class="title" id="CD010106-sec-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL; 2014, Issue 8), MEDLINE (OvidSP) (January 1966 to August 2014), EMBASE (OvidSP) (January 1980 to August 2014) and ISI Web of Science (January 1955 to August 2014). We also searched relevant clinical trial registries and conference proceedings. </p> </section> <section id="CD010106-sec-0004"> <h3 class="title" id="CD010106-sec-0004">Selection criteria</h3> <p>We included randomized controlled trials (RCTs) of any drug in the treatment of nausea and vomiting in the treatment of adults in the ED. Study eligibility was not restricted by language or publication status. </p> </section> <section id="CD010106-sec-0005"> <h3 class="title" id="CD010106-sec-0005">Data collection and analysis</h3> <p>Two review authors independently performed study selection, data extraction and assessment of risk of bias in included studies. We contacted authors of studies to obtain missing information if required. </p> </section> <section id="CD010106-sec-0006"> <h3 class="title" id="CD010106-sec-0006">Main results</h3> <p>We included eight trials, involving 952 participants, of which 64% were women. Included trials were generally of adequate quality, with six trials at low risk of bias, and two trials at high risk of bias. Three trials with 518 participants compared five different drugs with placebo; all reported the primary outcome as mean change in visual analogue scale (VAS) (0 to 100) for nausea severity from baseline to 30 minutes. Trials did not routinely report other primary outcomes of the change in nausea VAS at 60 minutes or number of vomiting episodes. Differences in mean VAS change from baseline to 30 minutes between placebo and the drugs evaluated were: metoclopramide (three trials, 301 participants; mean difference (MD) ‐5.27, 95% confidence interval (CI) ‐11.33 to 0.80), ondansetron (two trials, 250 participants; MD ‐4.32, 95% CI ‐11.20 to 2.56), prochlorperazine (one trial, 50 participants; MD ‐1.80, 95% CI ‐14.40 to 10.80), promethazine (one trial, 82 participants; MD ‐8.47, 95% CI ‐19.79 to 2.85) and droperidol (one trial, 48 participants; MD ‐15.8, 95% CI ‐26.98 to ‐4.62). The only statistically significant change in baseline VAS to 30 minutes was for droperidol, in a single trial of 48 participants. No other drug was statistically significantly superior to placebo. Other included trials evaluated a drug compared to "active controls" (alternative antiemetic). There was no convincing evidence of superiority of any particular drug compared to active control. All trials included in this review reported adverse events, but they were variably reported precluding meaningful pooling of results. Adverse events were generally mild, there were no reported serious adverse events. Overall, the quality of the evidence was low, mainly because there were not enough data. </p> </section> <section id="CD010106-sec-0007"> <h3 class="title" id="CD010106-sec-0007">Authors' conclusions</h3> <p>In an ED population, there is no definite evidence to support the superiority of any one drug over any other drug, or the superiority of any drug over placebo. Participants receiving placebo often reported clinically significant improvement in nausea, implying general supportive treatment such as intravenous fluids may be sufficient for the majority of people. If a drug is considered necessary, choice of drug may be dictated by other considerations such as a person's preference, adverse‐effect profile and cost. The review was limited by the paucity of clinical trials in this setting. Future research should include the use of placebo and consider focusing on specific diagnostic groups and controlling for factors such as intravenous fluid administered. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010106-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010106-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010106-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010106-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010106-abs-0008">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD010106-abs-0007">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/pt#CD010106-abs-0006">Português</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010106-abs-0005" lang="en"> <h3>Medicines in the treatment of emergency department nausea and vomiting</h3> <p><b>Review question</b> </p> <p>We reviewed the effects of medicines in the treatment of nausea and vomiting in adults in the emergency department. </p> <p><b>Background</b> </p> <p>Nausea (feeling sick) and vomiting (being sick) is a common symptom in people in emergency departments, and can result from a number of different causes. In addition to being distressing, it can lead to other problems such as dehydration (where the body is losing more fluid than it is taking in). Medicines to treat nausea have been useful in other settings, such as after operations, although it is not known what is the best medicine for people in emergency departments. </p> <p><b>Study characteristics</b> </p> <p>The evidence is current to August 2014. We included eight clinical trials of 952 participants. The trials assessed many different medicines at different doses, but only three trials included a placebo group (dummy medication). Six of these trials were of high quality, with low risk of error (i.e. bias, where the true effect is exaggerated). For this review, we included the effects of the medicines on nausea and vomiting up to one hour after the medicine was given. </p> <p><b>Key results and quality of the evidence</b> </p> <p>The main results of interest were the effect on nausea between zero and 60 minutes after the medicine was given, number of vomits and side effects to medicines. Of these, only nausea at 30 minutes and side effects were reported by all trials. From all trials, only one medicine was reported to be better than placebo and other medicines. That was droperidol, which was included in one small trial of 97 participants. No other single medicine was definitely better than any other medicine, and none of the other trials that included a placebo group showed that the active medicines definitely worked better than the placebo. Side effects were mild. </p> <p>Our results suggest that in people in the emergency department, nausea will generally improve, whether they are treated with specific medicines or placebo. Therefore, supportive treatment, such as intravenous fluids (where fluid is given directly into a blood vessel) may be sufficient for many people. Overall, the quality of the evidence was low, mainly because there was not enough data. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010106-sec-0144" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010106-sec-0144">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010106-sec-0186">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010106-sec-0144"></div> <h3 class="title" id="CD010106-sec-0145">Implications for practice</h3> <section id="CD010106-sec-0145"> <p>The findings of this review suggest that in an emergency department (ED) population, nausea severity tends to decrease by a similar and apparently clinically significant amount over a period of 30 minutes, regardless of whether an antiemetic drug or saline placebo is given. Presumably this initial improvement is due to whatever specific therapies are provided for the person's underlying condition, probably including the provision of intravenous fluids. </p> <p>This review found no definite evidence to support the superiority of any one drug for the treatment of ongoing nausea, so choice of drug should be dictated by other considerations such as a person's preference, adverse‐effect profile and cost. </p> </section> <h3 class="title" id="CD010106-sec-0146">Implications for research</h3> <section id="CD010106-sec-0146"> <p>Evidence supports that any future ED‐based antiemetic studies should include a placebo control arm. Despite some likely variability in the minimum clinically significant difference (MCSD) for different populations, change in severity on the visual analogue scale (VAS) appears to be the most useful outcome measure in this setting, but the clinical importance of reductions greater than the MCSD warrants exploration. The change in number of vomiting episodes does not appear useful, and researchers should look to define need for rescue medication more tightly and what is contributing to a person's decision on satisfaction. </p> <p>Research to date has almost exclusively compared the effect on self reported nausea severity of a single dose of one drug over a time period of 30 minutes, with the clinical significance of the severity reduction at this time point also being based on somewhat limited literature. Further investigation of the MCSD for both global ED populations and in different initial severity subgroups would be useful. The effect of initial concurrent administration of different drugs on early reduction of symptoms, as often occurs in the oncology setting, could also be explored and compared to placebo. The longer‐term effect, still within the ED, of repeat doses of either the same or different drugs for persistent nausea might also be useful. </p> <p>Further research would also be useful in focusing on specific individual diagnostic groups within the ED population (e.g. presumed, uncomplicated gastroenteritis), which may demonstrate more consistent results from antiemetic drug administration, than the more heterogeneous undifferentiated ED population with nausea and vomiting. A further consideration in future trials would be to control the amount of intravenous fluid administered accurately, or to evaluate the antiemetic effects of intravenous fluid alone. </p> <p>Other participant‐related outcomes, still confined to the ED episode of care, such as change in severity by time of disposition, ED length of stay and need for hospital admission should be considered in future studies. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010106-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010106-sec-0029"></div> <div class="table" id="CD010106-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Metoclopramide for nausea and vomiting in the emergency department</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Metoclopramide for nausea and vomiting in the emergency department</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with nausea and vomiting </p> <p><b>Settings:</b> emergency department<br/> <b>Intervention:</b> metoclopramide </p> <p><b>Comparisons:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Metoclopramide</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in nausea severity at 30 minutes</b><br/> Visual analogue scale Scale from: 0 to 100<br/> Follow‐up: 30 minutes </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean nausea severity decrease ‐ metoclopramide vs. placebo ranged across control groups from<br/> <b>23 to 38 mm</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean nausea severity decrease ‐ metoclopramide vs. placebo in the intervention groups was<br/> <b>5.27 lower</b><br/> (11.33 lower to 0.8 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>301<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> low<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A larger decrease in nausea severity score indicates better control of symptoms. A difference of &gt; 15 mm is thought to be the 'minimum clinically significant difference' </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of vomiting episodes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>301</p> <p>(3 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>This outcome was not reported in any of the included studies</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse reactions</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>301</p> <p>(3 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No pooling of results was possible, due to variations in reporting. No studies reported any serious adverse reactions or significant difference in adverse reactions </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Proportion of participants requiring rescue medication</b> <br/> Physician's discretion<br/> Follow‐up: 60 minutes </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 0.3</b> <br/> (0.17 to 0.53) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>299<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> low<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>An OR &lt; 1 means less need for the medication with metoclopramide</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>381 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>156 per 1000</b><br/> (95 to 246) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>363 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>146 per 1000</b><br/> (88 to 232) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Participant satisfaction with intervention</b><br/> Self report </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 1.07</b> <br/> (0.6 to 1.91) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>216<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> low<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>An OR &lt; 1 implies better satisfaction with metoclopramide</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>657 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>672 per 1000</b><br/> (535 to 785) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>721 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>734 per 1000</b><br/> (608 to 832) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>OR:</b> odds ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded for imprecision (wide confidence interval and not achieving optimal information size).<br/> <sup>2</sup> Downgraded as this outcome was poorly described and variable in the included trials and imprecision. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010106-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010106-sec-0030">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010106-sec-0166">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD010106-sec-0030"></div> <section id="CD010106-sec-0031"> <h3 class="title" id="CD010106-sec-0031">Description of the condition</h3> <p>Nausea and vomiting is a common and distressing presenting complaint in emergency departments (ED) with more than eight million presentations annually in the US (<a href="./references#CD010106-bbs2-0032" title="LaValleyJ , CrandallC , BraudeD . Nausea and vomiting management in US emergency departments (abstract). Academic Emergency Medicine2003;10:461. ">LaValley 2003</a>). Nausea describes the unpleasant sensation of the imminent need to vomit, whereas vomiting refers to the forceful oral expulsion of gastric contents associated with contraction of the abdominal and chest wall musculature (<a href="./references#CD010106-bbs2-0038" title="QuigleyEMM , HaslerWL , ParkmanHP . AGA technical review on nausea and vomiting. Gastroenterology2001;120(1):263‐86. [DOI: 10.1053/gast.2001.20516; PUBMED: 11208736] ">Quigley 2001</a>). Therefore, whereas nausea is a subjective experience, vomiting represents a physical event. </p> <p>Nausea and vomiting can be extremely distressing and complications can range from trivial to serious, for example, dehydration, electrolyte disturbance, aspiration, Mallory‐Weiss syndrome (tears of gastric and oesophageal mucosa) and oesophageal rupture (<a href="./references#CD010106-bbs2-0020" title="BorkB , DitkoffJ , HangBS . Nausea and vomiting. In: TintinalliJE editor(s). Tintinalli's Emergency Medicine: a Comprehensive Study Guide. 7th Edition. New York: McGraw Hill Medical, 2011. [ISBN: 0071484809] ">Bork 2011</a>; <a href="./references#CD010106-bbs2-0040" title="ZunLS , SinghA . Nausea and vomiting. In: MarxJA editor(s). Rosen's Emergency Medicine: Concepts and Clinical Practice. Philadelphia: Mosby Elsevier, 2010. [ISBN: 978‐0‐323‐05472‐0] ">Zun 2010</a>). The most common cause of nausea and vomiting in the ED is acute gastroenteritis (inflammation of the gastrointestinal tract); however, the aetiology of nausea and vomiting in the ED setting is diverse and may include physiological and pathological responses of the gastrointestinal tract, central nervous system disorders, endocrine or metabolic problems and toxins or medications, among others (<a href="./references#CD010106-bbs2-0040" title="ZunLS , SinghA . Nausea and vomiting. In: MarxJA editor(s). Rosen's Emergency Medicine: Concepts and Clinical Practice. Philadelphia: Mosby Elsevier, 2010. [ISBN: 978‐0‐323‐05472‐0] ">Zun 2010</a>). Nausea and vomiting in the ED may co‐exist with other medical conditions (e.g. myocardial infarction or small bowel obstruction) or result from other treatments prescribed in the ED (e.g. opiate analgesia) </p> </section> <section id="CD010106-sec-0032"> <h3 class="title" id="CD010106-sec-0032">Description of the intervention</h3> <p>ED management of a patient often involves identification of the cause of nausea and vomiting as well as recognition and correction of consequences and complications (<a href="./references#CD010106-bbs2-0018" title="AGA . American Gastroenterological Association medical position statement: nausea and vomiting. Gastroenterology2001;120(1):261‐2. [DOI: l0.l053/gast,2001.20515] ">AGA 2001</a>; <a href="./references#CD010106-bbs2-0038" title="QuigleyEMM , HaslerWL , ParkmanHP . AGA technical review on nausea and vomiting. Gastroenterology2001;120(1):263‐86. [DOI: 10.1053/gast.2001.20516; PUBMED: 11208736] ">Quigley 2001</a>). Antiemetics are commonly prescribed for undifferentiated nausea and vomiting in the ED setting, although there is little consensus as to the optimum management. Therapy is often directed at the presumed pathophysiological cause or extrapolated from evidence in other settings. </p> </section> <section id="CD010106-sec-0033"> <h3 class="title" id="CD010106-sec-0033">How the intervention might work</h3> <p>The pathophysiology of nausea and vomiting is a complex process. The physical aspect of vomiting is co‐ordinated by the vomiting centre of the brain, functionally located in the lateral reticular formation of the medulla. Efferent pathways from the vomiting centre are mainly through the vagus, phrenic and spinal nerves (<a href="./references#CD010106-bbs2-0040" title="ZunLS , SinghA . Nausea and vomiting. In: MarxJA editor(s). Rosen's Emergency Medicine: Concepts and Clinical Practice. Philadelphia: Mosby Elsevier, 2010. [ISBN: 978‐0‐323‐05472‐0] ">Zun 2010</a>). The vomiting centre receives afferent input from various sources including the chemoreceptor trigger zone (CTZ) located in the area postrema in the floor of the fourth ventricle, the vagus and sympathetic nerves, as well as impulses directly from the gastrointestinal tract and other sources (<a href="./references#CD010106-bbs2-0020" title="BorkB , DitkoffJ , HangBS . Nausea and vomiting. In: TintinalliJE editor(s). Tintinalli's Emergency Medicine: a Comprehensive Study Guide. 7th Edition. New York: McGraw Hill Medical, 2011. [ISBN: 0071484809] ">Bork 2011</a>; <a href="./references#CD010106-bbs2-0022" title="CarpenterDO . Neural mechanisms of emesis. Canadian Journal of Physiology and Pharmacology1990;68:230‐6. [PUBMED: 2178747] ">Carpenter 1990</a>). The CTZ is also activated by mediators in the circulation, which may include hormones, peptides, medications or toxins (<a href="./references#CD010106-bbs2-0040" title="ZunLS , SinghA . Nausea and vomiting. In: MarxJA editor(s). Rosen's Emergency Medicine: Concepts and Clinical Practice. Philadelphia: Mosby Elsevier, 2010. [ISBN: 978‐0‐323‐05472‐0] ">Zun 2010</a>). </p> <p>Reflecting the complex nature of the process of nausea and vomiting, antiemetics consist of a diverse group of chemicals with varying mechanisms and sites of action. Targets of action include the CTZ through dopamine receptors, serotonin receptors in the area postrema and nucleus tractus solitarius, and cholinergic and histamine receptors. Other agents have their action peripherally on the gastrointestinal tract, and for others the mechanism of action is incompletely understood. </p> </section> <section id="CD010106-sec-0034"> <h3 class="title" id="CD010106-sec-0034">Why it is important to do this review</h3> <p>High‐level evidence supports the use of antiemetics in the management of nausea and vomiting in many settings and populations; however, there is little guidance or consensus in recommendations for the management of nausea and vomiting in the adult ED setting. Recommendations are inconsistent and rarely evidence based. Preferred pharmacological agents differ significantly between countries and regions (<a href="./references#CD010106-bbs2-0032" title="LaValleyJ , CrandallC , BraudeD . Nausea and vomiting management in US emergency departments (abstract). Academic Emergency Medicine2003;10:461. ">LaValley 2003</a>; <a href="./references#CD010106-bbs2-0036" title="MeeMJ , Egerton‐WarburtonD , MeekR . Treatment and assessment of emergency department nausea and vomiting in Australasia: a survey of anti‐emetic management. Emergency Medicine Australasia2011;23:162‐8. [DOI: 10.1111/j.1742‐6723.2011.01386.x; PUBMED: 21489163] ">Mee 2011</a>). Postoperative nausea and vomiting (<a href="./references#CD010106-bbs2-0021" title="CarlisleJ , StevensonCA . Drugs for preventing postoperative nausea and vomiting. Cochrane Database of Systematic Reviews2006, Issue 3. [DOI: 10.1002/14651858.CD004125.pub2] ">Carlisle 2006</a>), chemotherapy (<a href="./references#CD010106-bbs2-0019" title="BillioA , MorelloE , ClarkeMJ . Serotonin receptor antagonists for highly emetogenic chemotherapy in adults. Cochrane Database of Systematic Reviews2010, Issue 1. [DOI: 10.1002/14651858.CD006272.pub2] ">Billio 2010</a>; <a href="./references#CD010106-bbs2-0030" title="JordanK , SippelC , SchmollH . Guidelines for antiemetic treatment of chemotherapy‐induced nausea and vomiting: past, present, and future recommendations. Oncologist2007;12:1143‐50. [PUBMED: 17914084] ">Jordan 2007</a>), and radiotherapy (<a href="./references#CD010106-bbs2-0031" title="American Society of Clinical Oncology, KrisMG , HeskethPJ , SomerfieldMR , FeyerP , Clark‐SnowR , KoellerJM , et al. American Society of Clinical Oncology guideline for antiemetics in oncology: update. Journal of Clinical Oncology2006;24(18):2932‐47. [PUBMED: 16717289] ">Kris 2006</a>; <a href="./references#CD010106-bbs2-0034" title="MaranzanoE , FeyerP , MolassiotisA , RossiR , Clark‐SnowR , OlverI , et al. Evidence‐based recommendations for the use of antiemetics in radiotherapy. Radiotherapy &amp; Oncology2005;76(3):227‐33. [PUBMED: 16150504] ">Maranzano 2005</a>) induced nausea and vomiting, in particular, have been extensively researched with systematic reviews and guidelines published. Cochrane systematic reviews have also been published on antiemetic use in people receiving palliative care (<a href="./references#CD010106-bbs2-0023" title="Dorman , S , Perkins , P . Droperidol for treatment of nausea and vomiting in palliative care patients. Cochrane Database of Systematic Reviews2010, Issue 10. [DOI: 10.1002/14651858.CD006938.pub2] ">Dorman 2010</a>; <a href="./references#CD010106-bbs2-0037" title="PerkinsP , DormanS . Haloperidol for the treatment of nausea and vomiting in palliative care patients. Cochrane Database of Systematic Reviews2009, Issue 2. [DOI: 10.1002/14651858.CD006271.pub2] ">Perkins 2009</a>), paediatric and adolescent gastroenteritis (<a href="./references#CD010106-bbs2-0026" title="FedorowiczZ , JagannathVA , CarterB . Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents. Cochrane Database of Systematic Reviews2011, Issue 9. [DOI: 10.1002/14651858.CD005506.pub5] ">Fedorowicz 2011</a>), nausea and vomiting associated with early pregnancy (<a href="./references#CD010106-bbs2-0035" title="MathewsA , DowswellT , HassDM , DoyleM , O'MathunaDP . Interventions for nausea and vomiting in early pregnancy. Cochrane Database of Systematic Reviews2010, Issue 9. [DOI: 10.1002/14651858.CD007575.pub2] ">Mathews 2010</a>), and the use of acupuncture pressure points (<a href="./references#CD010106-bbs2-0025" title="EzzoJ , RichardsonMA , VickersA , AllenC , DibbleS , IssellBF , et al. Acupuncture‐point stimulation for chemotherapy‐induced nausea or vomiting. Cochrane Database of Systematic Reviews2006, Issue 2. [DOI: 10.1002/14651858.CD002285.pub2] ">Ezzo 2006</a>; <a href="./references#CD010106-bbs2-0033" title="LeeA , FanLTY . Stimulation of the wrist acupuncture point P6 for preventing postoperative nausea and vomiting. Cochrane Database of Systematic Reviews2009, Issue 2. [DOI: 10.1002/14651858.CD003281.pub3] ">Lee 2009</a>). However, extrapolation of the evidence from these settings to the ED population is not straightforward because of differences in aetiologies, patient populations and other factors. This review is important to help establish the current evidence for management of nausea and vomiting in this clinically diverse setting, and to help determine future research priorities. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010106-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010106-sec-0035">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010106-sec-0171">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010106-sec-0035"></div> <p>To provide evidence of the efficacy and safety of antiemetic medications in the management of nausea and vomiting in the adult ED setting. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010106-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010106-sec-0036">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010106-sec-0172">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010106-sec-0036"></div> <section id="CD010106-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010106-sec-0038"> <h4 class="title">Types of studies</h4> <p>We included randomized controlled trials (RCTs) of any drug in the treatment of nausea and vomiting in the ED setting. We did not restrict the study eligibility by language or publication status. We excluded prospective cohort studies and quasi‐randomized studies. </p> </section> <section id="CD010106-sec-0039"> <h4 class="title">Types of participants</h4> <p>We included adult ED participants aged 16 years and older with nausea and vomiting. We only included trials if the study participants were identified as an 'adult', or if over 80% of the participants were aged over 16 years. We contacted study authors if age data were not available, and we did not include studies in this review if ages of the participants were not clear. We clearly identified the setting as ED. </p> </section> <section id="CD010106-sec-0040"> <h4 class="title">Types of interventions</h4> <p>Interventions included any pharmacological agent prescribed for the treatment of nausea and vomiting. We considered any dose, formulation or route of administration. Appropriate comparators included placebo, no treatment or "active control" (alternative antiemetic). </p> </section> <section id="CD010106-sec-0041"> <h4 class="title">Types of outcome measures</h4> <p>Severity of nausea, as assessed by use of any scale or score, and number of vomiting episodes. </p> <section id="CD010106-sec-0042"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD010106-list-0001"> <li> <p>Severity of nausea. Nausea was assessed as measured on any scale or score used by study authors, and transformed if required to a score between 0 and 100. It was recorded as complete resolution of nausea (e.g. including score 0 on a visual analogue scale (VAS)) and change from baseline value, with a minimum clinically significant difference (MCSD) from baseline defined as 15 mm on the VAS (<a href="./references#CD010106-bbs2-0028" title="HendeyGW , DonnerNF , FullerK . Clinically significant changes in nausea as measured on a visual analog scale. Annals of Emergency Medicine2005;45(1):77‐81. [DOI: 10.1016/j.annemergmed.2004.07.446; PUBMED: 15635314 ] ">Hendey 2005</a>). We included time points between zero and 60 minutes as relevant to the practice of emergency medicine. </p> </li> <li> <p>Number of vomiting episodes, both self reported and clinician‐reported outcomes.</p> </li> <li> <p>Any adverse reactions.</p> </li> </ol> </p> </section> <section id="CD010106-sec-0043"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD010106-list-0002"> <li> <p>Proportion of participants requiring rescue medication.</p> </li> <li> <p>Proportion of participants who required hospital admission.</p> </li> <li> <p>Mean or median ED length of stay.</p> </li> <li> <p>Participant satisfaction with intervention.</p> </li> </ol> </p> </section> </section> </section> <section id="CD010106-sec-0044"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD010106-sec-0045"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL; 2014, Issue 8), MEDLINE (OvidSP) (January 1966 to August 2014), EMBASE (OvidSP) (January 1980 to August 2014) and ISI Web of Science (January 1955 to August 2014). The search used a combination of text words and MeSH, with no language restriction. We developed a specific strategy for each database. The search strategy for MEDLINE is outlined in <a href="./appendices#CD010106-sec-0150">Appendix 1</a>, which contains the Cochrane highly sensitive search strategy (<a href="./references#CD010106-bbs2-0029" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). Search strategies for EMBASE (<a href="./appendices#CD010106-sec-0151">Appendix 2</a>) and CENTRAL (<a href="./appendices#CD010106-sec-0152">Appendix 3</a>) are also included. </p> </section> <section id="CD010106-sec-0046"> <h4 class="title">Searching other resources</h4> <p>We handsearched the reference lists of identified papers to identify further relevant trials. We examined clinical trial registries for unpublished trials on the International Clinical Trials Registry Platform (<a href="http://www.who.int/ictrp/en/" target="_blank">www.who.int/ictrp/en/</a>), USA Clinical Trials registry (<a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov/</a>), and Controlled Trials metaRegister of Controlled Trials (<a href="http://www.controlled-trials.com/mRCT" target="_blank">www.controlled‐trials.com/mRCT</a> and <a href="http://www.controlled-trials.com/mrct/archived" target="_blank">www.controlled‐trials.com/mrct/archived</a>), and contacted study authors. We handsearched key journals (<i>Annals of Emergency Medicine</i> , <i>Academic Emergency Medicine</i> , <i>Emergency Medicine</i> , <i>Journal of Emergency Medicine and Emergency Medicine Australasia</i>) from January 2009 to August 2014. </p> <p>We also handsearched the published abstracts from relevant conference proceedings for additional unpublished trials. The conferences searched included: </p> <p> <ol id="CD010106-list-0003"> <li> <p>Society for Academic Emergency Medicine (SAEM) Annual Meeting ‐ Academic Emergency Medicine (1996 to August 2014); </p> </li> <li> <p>American College of Emergency Physicians (ACEP) Scientific Assembly/Research Forum (1996 to August 2014); </p> </li> <li> <p>Canadian Association of Emergency Medicine (CAEM) Annual Conference ‐ <i>Canadian Journal of Emergency Medicine</i>; </p> </li> <li> <p>Australasian College of Emergency Medicine (ACEM) ‐ Annual Scientific Meeting ‐ Emergency Medicine Australasia (2004 to August 2014); </p> </li> <li> <p>College of Emergency Medicine (UK) Scientific conference (2006 to August 2014) ‐ <i>Emergency Medicine Journal</i> ‐ supplements; </p> </li> <li> <p>European Society for Emergency Medicine (EuSEM) Mediterranean Emergency Medicine Congress ‐ <i>European Journal of Emergency Medicine</i>. </p> </li> </ol> </p> <p>We contacted other experts in the field to provide details of any ongoing clinical trials or unpublished materials. </p> </section> </section> <section id="CD010106-sec-0047"> <h3 class="title" id="CD010106-sec-0047">Data collection and analysis</h3> <section id="CD010106-sec-0048"> <h4 class="title">Selection of studies</h4> <p>We merged the search results with reference management software and removed duplicates. Two review authors (JF and RM) independently assessed titles and abstracts from studies identified by the search. We obtained full copies of all relevant or potentially relevant studies identified by either review author. We planned to obtain translations, if necessary, and contacted study authors for clarification, if necessary. </p> <p>Two review authors (JF and RM) independently applied inclusion and exclusion criteria, and confirmed eligibility using a checklist in the data collection form (<a href="./appendices#CD010106-sec-0154">Appendix 5</a>), which we developed for this review. We resolved disagreements by consensus or by consulting the third review author (DEW). We listed the characteristics of key excluded studies in the <a href="./references#CD010106-sec-0164" title="">Characteristics of excluded studies</a> table. </p> </section> <section id="CD010106-sec-0049"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (JF and RM) independently extracted data using a specifically designed, piloted data collection form. We resolved discrepancies by consensus and by consulting the third review author (DEW). One review author (JF) entered data into Review Manager 5 (<a href="./references#CD010106-bbs2-0039" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). </p> </section> <section id="CD010106-sec-0050"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (JF and RM) independently assessed methodological quality of the eligible trials. We resolved disagreements by discussion and, if we could not reach a consensus, a third review author (DEW) arbitrated. </p> <p>We performed risk of bias assessment using the 'Risk of bias' tool described in Chapter 8 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010106-bbs2-0029" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). We assessed each trial according to the quality domains of random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective reporting and any other potential threats to validity (<a href="./appendices#CD010106-sec-0154">Appendix 5</a>). </p> <p>We considered a trial as having a low risk of bias if we assessed all domains as adequate. We considered a trial as having a high risk of bias if we assessed two or more domains as inadequate or unclear, or if we considered any one of the domains of allocation concealment, blinding participants or personnel, or blinding outcome assessors inadequate or unclear. We performed sensitivity analysis to determine whether excluding studies at high risk of bias affected the results of the meta‐analysis. </p> <p>We reported the 'Risk of bias' table as part of the <a href="./references#CD010106-sec-0163" title="">Characteristics of included studies</a> table and presented a 'Risk of bias' summary figure, which detailed all of the judgements made for all included studies in the review. </p> </section> <section id="CD010106-sec-0051"> <h4 class="title">Measures of treatment effect</h4> <p>We reported the primary outcomes of included studies as either a dichotomous or continuous variable, for example vomiting yes or no; or nausea VAS score. We reported dichotomous outcomes as number and proportions and present continuous outcomes as mean change. </p> </section> <section id="CD010106-sec-0052"> <h4 class="title">Unit of analysis issues</h4> <p>We used only individual level data.</p> </section> <section id="CD010106-sec-0053"> <h4 class="title">Dealing with missing data</h4> <p>We contacted study authors by e‐mail with requests to provide missing data. We intended to use imputation methods for missing data using 'worst‐case', 'best‐case' and 'average‐case' scenarios for the primary outcome of change in nausea severity, and perform sensitivity analyses to assess how sensitive results were to assumptions made. </p> </section> <section id="CD010106-sec-0054"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed for statistical heterogeneity by visual inspection of the confidence intervals (CI) of forest plot results, P value &lt; 0.05 for Chi<sup>2</sup> test and I<sup>2</sup> statistic with a value &gt; 50% indicating significant heterogeneity (<a href="./references#CD010106-bbs2-0029" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). In addition, we assessed for clinical heterogeneity with consideration of the characteristics of included studies regarding participants, interventions and outcome measures. We presented the primary analysis using the random‐effects model to account for clinical heterogeneity. </p> </section> <section id="CD010106-sec-0055"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned to test for funnel plot asymmetry using weighted linear regression of effect estimates on their standard error (<a href="./references#CD010106-bbs2-0024" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta‐analysis detected by a simple, graphical test. BMJ (Clinical Research Ed)1997;315(71091):629‐34. [PUBMED: 9310563] ">Egger 1997</a>), if we included more than 10 trials. However, we included only eight studies in this review. </p> </section> <section id="CD010106-sec-0056"> <h4 class="title">Data synthesis</h4> <p>We based outcome data on intention‐to‐treat analysis results. We combined data from dichotomous and continuous outcomes and performed meta‐analysis using Review Manager 5 when data from two or more RCTs were sufficient (<a href="./references#CD010106-bbs2-0039" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). For trials with multiple intervention groups, we combined groups to create single pair‐wise comparisons as outlined in Chapter 16.5.4 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010106-bbs2-0029" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). For dichotomous outcomes, we summed both the sample sizes and the numbers of people with events across groups, and for continuous outcomes, we combined means and standard deviations (SD) using the methods described in Section 7.7.3.8 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010106-bbs2-0029" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). We used odds ratio (OR) to measure the treatment effect of dichotomous outcomes and the mean difference (MD) for continuous data using the inverse variance method. We used random‐effects model for analyses due to clinical heterogeneity of interventions and outcomes. When it was not appropriate to combine results, we presented them in narrative form. </p> </section> <section id="CD010106-sec-0057"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to perform subgroup analysis on nausea and vomiting associated with pregnancy, opiate administration and chemotherapy. This analysis was not possible as no data were available. </p> </section> <section id="CD010106-sec-0058"> <h4 class="title">Sensitivity analysis</h4> <p>We performed sensitivity analyses using both the fixed‐effect and random‐effects models, and the effect on the overall primary results by excluding studies at high risk of bias (as defined above). </p> <section id="CD010106-sec-0059"> <h5 class="title">'Summary of findings' tables</h5> <p>We used the principles of the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) system (<a href="./references#CD010106-bbs2-0027" title='GuyattGH , OxmanAD , KunzR , VistGE , Falck‐YtterY , SchunemannHJ . What is "quality of evidence" and why is it important to clinicians. BMJ2008;336:995‐8. [PUBMED: 18456631] '>Guyatt 2008</a>) to assess the quality of the body of evidence associated with the specific outcomes change in nausea severity number of vomiting episodes, adverse reactions, proportion of participants requiring rescue medication and participant satisfaction with intervention, in our review and constructed <a href="./full#CD010106-tbl-0001">summary of findings Table for the main comparison</a> using GRADE software. The GRADE approach appraises the quality of a body of evidence based on the extent to which one can be confident that an estimate of effect or association reflects the item being assessed. The quality of a body of evidence considers within‐study risk of bias (methodological quality), directness of the evidence, heterogeneity of the data, precision of effect estimates and risk of publication bias. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010106-sec-0060" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010106-sec-0060"></div> <section id="CD010106-sec-0061"> <h3 class="title">Description of studies</h3> <section id="CD010106-sec-0062"> <h4 class="title">Results of the search</h4> <p>The electronic search identified 6799 studies with duplicates removed, consisting of 1389 from EMBASE, 3630 from MEDLINE, 320 from CENTRAL and 2507 from Web of Science. After screening titles and abstracts, we identified 13 studies for examination of the full text. We identified eight relevant studies from searching conference proceedings and clinical trial registries. Four of the studies appeared to report unique studies of relevance to our review, whereas four of the studies reported data subsequently published in journals and identified by the electronic database search. We contacted authors of the four other studies, but received no data from investigators, meaning information was only available in abstract form. Two of the authors of this Cochrane review were co‐authors of the <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a> study. Therefore, the search yielded 17 studies for consideration for inclusion. After evaluation of the full‐text articles, we included eight studies in the review (see <a href="./references#CD010106-sec-0163" title="">Characteristics of included studies</a> table), we excluded five studies (see <a href="./references#CD010106-sec-0164" title="">Characteristics of excluded studies</a> table), and we identified four studies that were available in abstract form, and had insufficient information to assess (see <a href="./references#CD010106-sec-0165" title="">Characteristics of studies awaiting classification</a> table). For a PRISMA flow diagram of search strategy, see <a href="#CD010106-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD010106-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD010106-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD010106-sec-0063"> <h4 class="title">Included studies</h4> <p>We included eight trials in this review (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>; <a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>; <a href="./references#CD010106-bbs2-0005" title="ChamS , BasireM , KellyA‐M . Intermediate dose metoclopramide is not more effective than standard dose metoclopramide for patients who present to the emergency department with nausea and vomiting: a pilot study. Emergency Medicine Australasia2004;16(3):208‐11. [PUBMED: 15228463] ">Cham 2004</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>; <a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a>; <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>). Further details are available in the <a href="./references#CD010106-sec-0163" title="">Characteristics of included studies</a> table. </p> <section id="CD010106-sec-0064"> <h5 class="title">Design</h5> <p>The eight included trials were all parallel group, randomized trials. One trial was described as single blind (<a href="./references#CD010106-bbs2-0005" title="ChamS , BasireM , KellyA‐M . Intermediate dose metoclopramide is not more effective than standard dose metoclopramide for patients who present to the emergency department with nausea and vomiting: a pilot study. Emergency Medicine Australasia2004;16(3):208‐11. [PUBMED: 15228463] ">Cham 2004</a>), the remainder were described as double blind. The included trials had two to four treatment arms, with only three trials including a placebo arm (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>), the other trials using an active control. One trial was described as a non‐inferiority trial (<a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>). The total sample size was 952 participants, consisting of 338 men and 614 women. </p> </section> <section id="CD010106-sec-0065"> <h5 class="title">Participants and setting</h5> <p>The included trials were conducted in EDs in the US and Australia, mostly identified as university affiliated or teaching hospitals. All only included adults aged over 18 years. Most trials included nausea and vomiting from a variety of aetiologies, three trials excluded participants if their initial nausea VAS score was less than 40 mm (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>). One trial specified the requirement for "uncomplicated gastritis and gastroenteritis" for eligibility (<a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a>). Women outnumbered men in all trials. </p> </section> <section id="CD010106-sec-0066"> <h5 class="title">Intervention</h5> <p>The trials evaluated six different antiemetics. All trials included only intravenous antiemetics. Two trials had four arms (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>), and one trial had three arms (<a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>). Only three trials included a placebo arm (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>). Five trials evaluated metoclopramide in doses of 10 mg, 20 mg and 0.4 mg/kg up to 32 mg. One trial compared two different doses of metoclopramide (<a href="./references#CD010106-bbs2-0005" title="ChamS , BasireM , KellyA‐M . Intermediate dose metoclopramide is not more effective than standard dose metoclopramide for patients who present to the emergency department with nausea and vomiting: a pilot study. Emergency Medicine Australasia2004;16(3):208‐11. [PUBMED: 15228463] ">Cham 2004</a>). Five trials evaluated 5‐hydroxytryptamine‐3 (5‐HT3) blockers (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>; <a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>; <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>), four using ondansetron 4 mg (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>; <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>), and one using tropisetron 0.5 mg (<a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>). Three trials included prochlorperazine 10 mg (<a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a>; <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>); three trials evaluated promethazine, one trial at 12.5 mg (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>), and two trials at 25 mg (<a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>; <a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a>). All trials involved administration of a single stat dose as a bolus or over two to five minutes. Most trials included administration of varying amounts of intravenous fluid during the study period. </p> </section> <section id="CD010106-sec-0067"> <h5 class="title">Outcomes</h5> <p>All included studies reported the primary outcome of severity of nausea reported on any scale or score. Seven of the studies reported nausea on a 100‐mm VAS (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>; <a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>; <a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a>; <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>), and one study used a 0 to 10 numerical rating scale (NRS) (<a href="./references#CD010106-bbs2-0005" title="ChamS , BasireM , KellyA‐M . Intermediate dose metoclopramide is not more effective than standard dose metoclopramide for patients who present to the emergency department with nausea and vomiting: a pilot study. Emergency Medicine Australasia2004;16(3):208‐11. [PUBMED: 15228463] ">Cham 2004</a>). All studies included the time point of 30 minutes; three trials also reported data at 60 minutes (<a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>; <a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a>; <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>); two trials reported outcomes beyond 60 minutes that we did not consider relevant to this review (<a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>; <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>). </p> <p>Three trials reported the number of vomiting episodes (<a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>; <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>). All trials reported adverse events, but the trials classified and reported them differently. All trials reported the outcome of requirement for rescue medication, but this was variably defined, or not defined in trials. Three trials reported the proportion of participants requiring hospital admission (<a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>; <a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a>; <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>). No trials reported on ED length of stay, while three reported participant satisfaction (<a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>). </p> </section> </section> <section id="CD010106-sec-0068"> <h4 class="title">Excluded studies</h4> <p>We excluded five studies; see <a href="./references#CD010106-sec-0164" title="">Characteristics of excluded studies</a> table for details. The study by <a href="./references#CD010106-bbs2-0012" title="RoyP , PatelN , MillerA . A comparison of controlled release metoclopramide and domperidone in the treatment of nausea and vomiting. British Journal of Clinical Practice1991;45(4):247‐51. [PUBMED: 1810356] ">Roy 1991</a> compared oral doses of metoclopramide and domperidone, three times a day over one week. The setting appeared to be in general practice and outcomes were measured beyond the time frame of relevance to this review. Another excluded trial, which evaluated one or two doses of intramuscular domperidone 10 mg versus placebo, measured outcomes beyond the relevant time frame and was not clearly identified as ED (<a href="./references#CD010106-bbs2-0009" title="AgorastosI , ZissisN , KaprinisI , GoulisG . Double‐blind evaluation of domperidone in acute vomiting and dyspeptic disorders. Journal of International Medical Research1981;9(2):143‐7. [PUBMED: 7014284] ">Agorastos 1981</a>). We excluded one report as it was not an RCT, but an uncontrolled prospective design with no appropriate comparator group (<a href="./references#CD010106-bbs2-0011" title="OrdogG , VannP , OwashiN , WasserbergerJ , HermanLS , BalasubramaniamS . Intravenous prochlorperazine for the rapid control of vomiting in the emergency department. Annals of Emergency Medicine1984;13:253‐8. [PUBMED: 6703431] ">Ordog 1984</a>). We excluded one large multicentre trial evaluating two different doses of ondansetron (8 mg and 16 mg) versus placebo for opiate‐associated nausea and vomiting (<a href="./references#CD010106-bbs2-0013" title="SussmanG , ShurmanJ , CreedM , LarsenL , Ferrer‐BrechnerT , NollD , et al. Intravenous ondansetron for the control of opioid‐induced nausea and vomiting. Clinical Therapeutics1999;21(7):1216‐27. [PUBMED: 10463519] ">Sussman 1999</a>). The setting was not clearly an ED, although it was stated that "many" participants were managed in EDs, and the primary outcome was resolution of symptoms at 24 hours, which was not relevant to this review. Finally, we excluded one single‐centre study from Israel because the setting was not an ED, but rather an outpatient setting, participants requiring intravenous treatment were excluded and time points of the outcome assessments were not of relevance to this review (<a href="./references#CD010106-bbs2-0010" title="CohenN , AlonI , Almoznino‐SarfianD , GorelikO , ChachasviliS , LitvinjukV , et al. Sulpiride versus metoclopramide in nononcologic patients with vomiting or nausea. Journal of Clinical Gastroenterology1999;21(1):59‐62. [PUBMED: 10405234] ">Cohen 1999</a>). </p> <section id="CD010106-sec-0069"> <h5 class="title">Awaiting classification</h5> <p>There are four trials awaiting classification (<a href="./references#CD010106-bbs2-0014" title="FriedlandH , DavidS , RenaeB , AmitS , LatisseM , MonicaS , et al. A randomized trial comparing the efficacy of low dose iv granisetron (0.1mg) versus iv prochlorperazine (10mg) in the treatment of acute nausea and vomiting. Proceedings of the Annual Meeting of the Society for Academic Emergency Medicine (SAEM); 2008 May 29‐June 1; Washington. Washington: Academic Emergency Medicine, 2008. ">Friedland 2008</a>; <a href="./references#CD010106-bbs2-0015" title="HaenselC , SmithD , PollackM , OwensL . Ondansetron versus metoclopramide for nausea and vomiting in the emergency department. Proceedings of the Annual Meeting of the Society for Academic Emergency Medicine; 2007 May 16‐19; Chicago. Chicago: Academic Emergency Medicine, 2007. ">Haensel 2007</a>; <a href="./references#CD010106-bbs2-0016" title="ThackerJ , MinerJ , BirosM . Droperidol versus metoclopramide for the treatment of nausea. Proceedings of the American College of Emergency Physicians; 2003 Oct 12‐13; Boston. Boston: American College of Emergency Physicians, 2003. ">Thacker 2003</a>; <a href="./references#CD010106-bbs2-0017" title="ThackerJ , MinerJ . Droperidol dosing for nausea and vomiting. Proceedings of the American College of Emergency Physicians; 2004 Oct 16‐18; San Francisco. San Francisco: American College of Emergency Physicians, 2004. ">Thacker 2004</a>; see <a href="./references#CD010106-sec-0165" title="">Characteristics of studies awaiting classification</a> table). These trials were available in abstract form only, with insufficient detail to allow inclusion in the review. We were unable to obtain further information from authors of these trials. </p> </section> <section id="CD010106-sec-0070"> <h5 class="title">Ongoing studies</h5> <p>We found no ongoing studies.</p> </section> </section> </section> <section id="CD010106-sec-0071"> <h3 class="title">Risk of bias in included studies</h3> <p>We assessed the risk of bias of each trial; see <a href="./references#CD010106-sec-0163" title="">Characteristics of included studies</a> table, <a href="#CD010106-sec-0050">Assessment of risk of bias in included studies</a> and 'Risk of bias' summary (<a href="#CD010106-fig-0002">Figure 2</a>; <a href="#CD010106-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD010106-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010106-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD010106-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010106-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD010106-sec-0072"> <h4 class="title">Allocation</h4> <p>All included trials reported acceptable methods of random sequence generation. The report by <a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a> reported only that drugs were "randomized in blocks of 10" and the method of sequence generation was not explicitly stated. This was clarified with the authors as being generated by computer program and recorded as low risk of bias for the review. Allocation concealment was adequate in seven out of eight studies. One study did not elucidate any mechanism of allocation concealment in the report, and was, therefore, considered unclear risk of bias (<a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>). </p> </section> <section id="CD010106-sec-0073"> <h4 class="title">Blinding</h4> <p>Blinding of participants and personnel was adequate in six trials (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>; <a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>; <a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a>), unclear in one trial (<a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>), and judged as high risk of bias in one trial (<a href="./references#CD010106-bbs2-0005" title="ChamS , BasireM , KellyA‐M . Intermediate dose metoclopramide is not more effective than standard dose metoclopramide for patients who present to the emergency department with nausea and vomiting: a pilot study. Emergency Medicine Australasia2004;16(3):208‐11. [PUBMED: 15228463] ">Cham 2004</a>). Outcomes were self reported in all included trials. The trial judged to be high risk of bias was reported as single blind, with no further details provided, but made no attempt to blind clinical staff (<a href="./references#CD010106-bbs2-0005" title="ChamS , BasireM , KellyA‐M . Intermediate dose metoclopramide is not more effective than standard dose metoclopramide for patients who present to the emergency department with nausea and vomiting: a pilot study. Emergency Medicine Australasia2004;16(3):208‐11. [PUBMED: 15228463] ">Cham 2004</a>). One other trial described preparation of the study drug by independent nurses from the usual ward stock, keeping the drug allocation concealed from the participant and treating doctor (<a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>). While we considered that this procedure could potentially compromise blinding, we thought this would have been unlikely to have occurred sufficiently to affect the outcome, and we, therefore, judged the trial to be low risk of bias for this domain. We assessed one trial as unclear risk of bias as the authors did not report any mechanism for blinding (<a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>). </p> <p>With regards to detection bias, outcomes were all self reported, consequently the same trial was rated as high risk of bias (<a href="./references#CD010106-bbs2-0005" title="ChamS , BasireM , KellyA‐M . Intermediate dose metoclopramide is not more effective than standard dose metoclopramide for patients who present to the emergency department with nausea and vomiting: a pilot study. Emergency Medicine Australasia2004;16(3):208‐11. [PUBMED: 15228463] ">Cham 2004</a>), and the same trial was reported as unclear risk of bias (<a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>) due to similar reasons as described above. </p> </section> <section id="CD010106-sec-0074"> <h4 class="title">Incomplete outcome data</h4> <p>All trials were at low risk of attrition bias. Although two trials had some unexplained missing data (<a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>; <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>), these appeared balanced between intervention groups, outside the time points considered most relevant to this review, and unlikely to have a significant impact on the intervention effect estimates. </p> </section> <section id="CD010106-sec-0075"> <h4 class="title">Selective reporting</h4> <p>There was no evidence of selective reporting in any of the trials. Outcomes listed in methods sections were reflected in results reported. One trial listed two primary outcomes on a clinical trial registry, and reported the non‐significant outcome as a secondary outcome in the published report (<a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>). However, as all results were reported, we considered this to be low risk of bias. </p> </section> <section id="CD010106-sec-0076"> <h4 class="title">Other potential sources of bias</h4> <p>We assessed two trials as 'unclear' with regards to other potential sources of bias. The <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a> trial was generally poorly reported, with inconsistencies throughout the report, and no reason given for non‐recruitment of substantial numbers of potentially eligible participants. The trial by <a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a> reported an unplanned interim analysis and post hoc power calculation. The trial was then stopped at just over one‐third of their planned recruitment target, because the likelihood of achieving a statistically significant result was remote, hence introducing the possibility of a type 2 error, which was acknowledged in the report. We judged that this may have introduced some bias. </p> </section> </section> <section id="CD010106-sec-0077"> <h3 class="title" id="CD010106-sec-0077">Effects of interventions</h3> <p>See: <a href="./full#CD010106-tbl-0001"><b>Summary of findings for the main comparison</b> Metoclopramide for nausea and vomiting in the emergency department</a> </p> <p>See <a href="./full#CD010106-tbl-0001">summary of findings Table for the main comparison</a> for the comparison of metoclopramide, the drug most commonly evaluated, versus placebo. </p> <p>This section included results from all eight trials. The three trials that included a placebo arm evaluated five different drugs: metoclopramide, ondansetron, prochlorperazine, promethazine and droperidol (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>). The five non‐placebo trials evaluated the same five drugs (<a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>; <a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>; <a href="./references#CD010106-bbs2-0005" title="ChamS , BasireM , KellyA‐M . Intermediate dose metoclopramide is not more effective than standard dose metoclopramide for patients who present to the emergency department with nausea and vomiting: a pilot study. Emergency Medicine Australasia2004;16(3):208‐11. [PUBMED: 15228463] ">Cham 2004</a>; <a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a>; <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>), with one trial including the 5‐HT3 blocker tropisetron (<a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>). </p> <p>To address the aims of this review, we combined the trials to allow comparisons of drugs versus placebo and each drug versus active control. Despite a degree of heterogeneity, this did allow for some pooling of results. We also presented the results of each drug studied versus each other drug. Some of these comparisons involved small numbers from one or two trials only, so caution is advised in interpretation of these findings. </p> <section id="CD010106-sec-0078"> <h4 class="title">Comparison of drug versus placebo</h4> <p>Three trials, with 518 participants, compared five different drugs with placebo (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>). </p> <section id="CD010106-sec-0079"> <h5 class="title">Primary outcomes</h5> <section id="CD010106-sec-0080"> <h6 class="title">Severity of nausea</h6> <p>All three trials reported the primary outcome of mean VAS rating change for nausea severity from baseline to 30 minutes (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>). </p> <p>All three trials evaluated metoclopramide and involved 301 participants. From pooled results, the MD in VAS rating change at 30 minutes between metoclopramide and placebo was ‐5.27 (95% CI ‐11.33 to 0.80) (<a href="#CD010106-fig-0004">Figure 4</a>). </p> <div class="figure" id="CD010106-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Metoclopramide versus placebo, outcome: 1.1 Change in nausea severity at 30 minutes." data-id="CD010106-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Metoclopramide versus placebo, outcome: 1.1 Change in nausea severity at 30 minutes. </p> </div> </div> </div> <p>Two trials evaluated ondansetron and involved 250 participants (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>). From pooled results, the MD in nausea VAS rating change at 30 minutes between ondansetron and placebo was ‐4.32 (95% CI ‐11.20 to 2.56) (<a href="./references#CD010106-fig-0009" title="">Analysis 2.1</a>). </p> <p>One trial each evaluated prochlorperazine (50 participants; <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>), promethazine (82 participants; <a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>), and droperidol (48 participants; <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>). The MD in VAS rating change at 30 minutes between prochlorperazine and placebo was ‐1.80 (95% CI ‐14.40 to 10.80) (<a href="#CD010106-tbl-0002">Table 1</a>). Between promethazine and placebo the MD was ‐8.47 (95% CI ‐19.79 to 2.85) (<a href="#CD010106-tbl-0003">Table 2</a>), and between droperidol and placebo the MD was ‐15.80 (95% CI ‐26.98 to ‐4.62) (<a href="#CD010106-tbl-0004">Table 3</a>). </p> <div class="table" id="CD010106-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Prochlorperazine versus placebo</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Statistical methods</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect estimate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change in nausea severity at 30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI [mm])</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.80 [‐14.40, 10.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants requiring rescue medication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.83 [0.45, 7.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Participant satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.91 [0.20, 4.13]</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Data from single trial comparing prochlorperazine versus placebo (<a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>). </p> <p>CI: confidence interval.</p> </div> </div> <div class="table" id="CD010106-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Promethazine versus placebo</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Statistical methods</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect estimate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change in nausea severity at 30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI [mm])</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐8.47 [‐19.79, 2.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants requiring rescue medication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.57 [0.24, 1.34]</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Data from single trial comparing promethazine versus placebo (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>). </p> <p>CI: confidence interval.</p> </div> </div> <div class="table" id="CD010106-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Droperidol versus placebo</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Statistical methods</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect estimate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change in nausea severity at 30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI [mm])</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐15.80 [‐26.98, ‐4.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants requiring rescue medication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.26 [0.03, 2.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Participant satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.82 [0.30, 11.02]</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Data from single trial comparing droperidol versus placebo (<a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>). </p> <p>CI: confidence interval.</p> </div> </div> <p>Only the result for droperidol favoured drug over placebo (<a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="#CD010106-tbl-0004">Table 3</a>). </p> </section> <section id="CD010106-sec-0081"> <h6 class="title">Number of vomiting episodes</h6> <p>One trial reported the reduction in number of vomiting episodes, which were similar for ondansetron (median 0, interquartile range (IQR) 0 to 1), metoclopramide (median 0, IQR 0 to 2) and placebo (median 0, IQR 0 to 1) (<a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>). The other two trials did not report the number of vomiting episodes (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>). </p> </section> <section id="CD010106-sec-0082"> <h6 class="title">Adverse reactions</h6> <p>All three trials reported adverse reactions (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>); however, differences in reporting precluded pooling of results. None of the trials reported any serious adverse events. </p> <p><a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>, evaluating ondansetron, metoclopramide and promethazine versus placebo, separately reported the proportion of participants with akathisia, headache and sedation at baseline and 30 minutes (characterized as none, mild, moderate and severe). These symptoms were commonly reported at baseline making interpretation of 30‐minute data problematic. At 30 minutes, akathisia was more common with each drug compared with placebo (4/38 (11%) with ondansetron, 11/41 (27%) with metoclopramide, 2/43 (5%) with promethazine, 1/38 with placebo). Headache was reported by 11/39 (28%) participants with ondansetron, 8/41 (20%) with metoclopramide and 12/43 (28%) with promethazine, compared with 6/38 (16%) with placebo. Sedation was reported by 16/39 (41%) participants with ondansetron, 21/40 (53%) with metoclopramide and 25/43 (58%) with promethazine, compared with 13/38 (34%) with placebo. </p> <p><a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a> reported mean and SD change in anxiety and sedation on a VAS from baseline to 30 minutes. For anxiety, the mean change for droperidol was ‐25.9 (SD 30.2), metoclopramide ‐25.4 (SD 24.3), prochlorperazine ‐21.9 (SD 38.8) and placebo ‐31.7 (SD 31.6); these differences were not significant (P value = 0.79). For sedation, the mean change for droperidol was 13.5 (SD 32.2), metoclopramide 0.4 (SD 30.1), prochlorperazine 5.1 (SD 26.5) and placebo ‐4.8 (SD 25.0); these differences were not significant (P value = 0.75). </p> <p><a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a> reported adverse events in 9/258 (3.5%) participants: six in participants who received metoclopramide (two akathisia, two restlessness, one sweatiness and one muscle twitching), two in participants who received ondansetron (one dizziness and one stinging at injection site) and one in a participant who received placebo (shaking and restlessness). </p> <p>The only significant result was a higher rate of akathisia for the "any drug" group compared with placebo (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>). </p> </section> </section> <section id="CD010106-sec-0083"> <h5 class="title">Secondary outcomes</h5> <section id="CD010106-sec-0084"> <h6 class="title">Proportion of participants requiring rescue medication</h6> <p>All three trials reported the proportion the participants requiring rescue medication, with 510 participants (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>). </p> <p>All three trials evaluated metoclopramide and included 299 participants (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>). The pooled outcome versus placebo favoured metoclopramide (OR 0.3, 95% CI 0.17 to 0.53) (<a href="./references#CD010106-fig-0007" title="">Analysis 1.2</a>). </p> <p>Two trials evaluated ondansetron and included 247 participants (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>). There was no difference in pooled outcome versus placebo for this outcome (OR 0.82, 95% CI 0.49 to 1.37) (<a href="./references#CD010106-fig-0010" title="">Analysis 2.2</a>). </p> <p>One trial each evaluated prochlorperazine (50 participants; <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>), promethazine (82 participants; <a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>), and droperidol (48 participants; <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>). There was no difference in outcome between any drug versus placebo (prochlorperazine: OR 1.83, 95% CI 0.45 to 7.51; <a href="#CD010106-tbl-0002">Table 1</a>; promethazine: OR 0.57, 95% CI 0.24 to 1.34; <a href="#CD010106-tbl-0003">Table 2</a> droperidol: OR 0.26, 95% CI 0.03 to 2.54; <a href="#CD010106-tbl-0004">Table 3</a>). </p> <p>The only result favouring a drug over placebo was for metoclopramide (<a href="./references#CD010106-fig-0007" title="">Analysis 1.2</a>). </p> </section> <section id="CD010106-sec-0085"> <h6 class="title">Proportion of participants who required hospital admission</h6> <p>None of the three trials including a placebo arm reported the proportion of participants who required hospital admission (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>). </p> </section> <section id="CD010106-sec-0086"> <h6 class="title">Mean or median emergency department length of stay</h6> <p>None of the three trials including a placebo arm reported the mean or median ED length of stay (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>). </p> </section> <section id="CD010106-sec-0087"> <h6 class="title">Participant satisfaction with intervention</h6> <p>Two trials reported participant satisfaction with intervention (<a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>). Both trials evaluated metoclopramide, involving 216 participants. From pooled results, there was no difference in participant satisfaction between metoclopramide and placebo (OR 1.07, 95% CI 0.60 to 1.91) (<a href="./references#CD010106-fig-0008" title="">Analysis 1.3</a>). </p> <p>One trial each evaluated ondansetron (164 participants; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>), droperidol (48 participants; <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>) and prochlorperazine (50 participants; <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>). There was no difference in satisfaction for ondansetron, droperidol or prochlorperazine versus placebo (ondansetron: OR 0.80, 95% CI 0.43 to 1.49; <a href="#CD010106-tbl-0005">Table 4</a> droperidol: OR 1.82, 95% CI 0.30 to 11.02; <a href="#CD010106-tbl-0004">Table 3</a> prochlorperazine: OR 0.91, 95% CI 0.20 to 4.13; <a href="#CD010106-tbl-0002">Table 1</a>). </p> <div class="table" id="CD010106-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Ondansetron versus placebo</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Statistical methods</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect estimate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Participant satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>164</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.80 [0.43, 1.49]</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Data from single trials comparing drug versus placebo.</p> <p>CI: confidence interval.</p> </div> </div> </section> </section> </section> <section id="CD010106-sec-0088"> <h4 class="title">Comparison of metoclopramide versus active control</h4> <p>Five trials with 528 participants evaluated metoclopramide against an active control (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>; <a href="./references#CD010106-bbs2-0005" title="ChamS , BasireM , KellyA‐M . Intermediate dose metoclopramide is not more effective than standard dose metoclopramide for patients who present to the emergency department with nausea and vomiting: a pilot study. Emergency Medicine Australasia2004;16(3):208‐11. [PUBMED: 15228463] ">Cham 2004</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>). </p> <section id="CD010106-sec-0089"> <h5 class="title">Primary outcomes</h5> <section id="CD010106-sec-0090"> <h6 class="title">Severity of nausea</h6> <p>One trial, involving 58 participants, compared metoclopramide 0.4 mg/kg (up to 32 mg) with a standard 10‐mg dose (<a href="./references#CD010106-bbs2-0005" title="ChamS , BasireM , KellyA‐M . Intermediate dose metoclopramide is not more effective than standard dose metoclopramide for patients who present to the emergency department with nausea and vomiting: a pilot study. Emergency Medicine Australasia2004;16(3):208‐11. [PUBMED: 15228463] ">Cham 2004</a>). The outcome was reported as change in severity on a NRS of nausea 0 to 10. The median reduction in nausea was 5 (95% CI 4 to 6) in the 0.4‐mg/kg group compared with 4 (95% CI 3 to 5) in the 10‐mg group. This difference was not statistically significant (P value = 0.63). </p> <p>The other four trials, involving 470 participants, included comparisons of metoclopramide with other active control, all reporting change in nausea severity on the VAS (mm) at 30 minutes (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>). From pooled results, the MD in VAS rating at 30 minutes between metoclopramide and any active control was ‐0.00 (95% CI ‐4.50 to 4.49) (<a href="./references#CD010106-fig-0011" title="">Analysis 3.1</a>). </p> <p>Three trials, involving 356 participants, compared metoclopramide with a 5‐HT3 antagonist (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>). From pooled results, the MD in VAS rating at 30 minutes between metoclopramide and 5‐HT3 antagonist was ‐1.74 (95% CI ‐6.88 to 3.40) (<a href="./references#CD010106-fig-0014" title="">Analysis 4.1</a>). Two of these trials, involving 256 participants, compared metoclopramide with ondansetron (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>), while the other trial, involving 100 participants, compared metoclopramide with tropisetron (<a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>). Separately for this outcome, the MDs were ‐2.00 (95% CI ‐8.30 to 4.29) (<a href="./references#CD010106-fig-0016" title="">Analysis 5.1</a>) for metoclopramide versus ondansetron and ‐1.20 (95% CI ‐10.11 to 7.71) (<a href="#CD010106-tbl-0006">Table 5</a>) for metoclopramide versus tropisetron. One trial, involving 83 participants, compared metoclopramide with promethazine (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>). The change in VAS rating at 30 minutes between metoclopramide and promethazine was 0.10 (95% CI ‐10.06 to 10.26) (<a href="#CD010106-tbl-0007">Table 6</a>). One trial compared metoclopramide with prochlorperazine (49 participants) and droperidol (47 participants) (<a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>). The change in VAS rating at 30 minutes (MD) between metoclopramide and prochlorperazine was 0.30 (95% CI ‐13.12 to 13.72) (<a href="#CD010106-tbl-0008">Table 7</a>), and between metoclopramide and droperidol was 14.30 (95% CI 2.21 to 26.39) (<a href="#CD010106-tbl-0009">Table 8</a>). </p> <div class="table" id="CD010106-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Metoclopramide versus tropisetron</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Statistical method</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect estimate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change in nausea severity at 30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI [mm])</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.20 [‐10.11, 7.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants requiring rescue medication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.16 [1.03, 9.69]</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Data from single trials comparing metoclopramide versus active control.</p> <p>CI: confidence interval.</p> </div> </div> <div class="table" id="CD010106-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Metoclopramide versus promethazine</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Statistical method</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect estimate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change in nausea severity at 30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI [mm])</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.10 [‐10.06, 10.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants requiring rescue medication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.36 [0.14, 0.93]</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Data from single trials comparing metoclopramide versus active control.</p> <p>CI: confidence interval.</p> </div> </div> <div class="table" id="CD010106-tbl-0008"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Metoclopramide versus prochlorperazine</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Statistical method</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect estimate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change in nausea severity at 30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI [mm])</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.30 [‐13.12, 13.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants requiring rescue medication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.13 [0.01, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Participant satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.05 [0.23, 4.78]</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Data from single trials comparing metoclopramide versus active control.</p> <p>CI: confidence interval.</p> </div> </div> <div class="table" id="CD010106-tbl-0009"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Metoclopramide versus droperidol</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Statistical method</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect estimate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change in nausea severity at 30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI [mm])</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.30 [2.21, 26.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants requiring rescue medication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.88 [0.05, 14.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Participant satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.53 [0.09, 3.19]</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Data from single trials comparing metoclopramide versus active control.</p> <p>CI: confidence interval.</p> </div> </div> <p>The only statistically significant result between metoclopramide and any active control was that favouring droperidol over metoclopramide (<a href="#CD010106-tbl-0009">Table 8</a>) (<a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>). </p> </section> <section id="CD010106-sec-0091"> <h6 class="title">Number of vomiting episodes</h6> <p>Four of the trials did not report the number of vomiting episodes within the time frame of interest to this review (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>; <a href="./references#CD010106-bbs2-0005" title="ChamS , BasireM , KellyA‐M . Intermediate dose metoclopramide is not more effective than standard dose metoclopramide for patients who present to the emergency department with nausea and vomiting: a pilot study. Emergency Medicine Australasia2004;16(3):208‐11. [PUBMED: 15228463] ">Cham 2004</a>). The related findings of <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a> have been previously described (see 'Comparison of drug versus placebo: Primary outcomes: Number of vomiting episodes'). </p> </section> <section id="CD010106-sec-0092"> <h6 class="title">Adverse reactions</h6> <p>All five trials reported adverse events; however, differences in reporting precluded pooling of results. None of the trials reported any serious adverse events. The most commonly reported adverse events were akathisia and headache. </p> <p><a href="./references#CD010106-bbs2-0005" title="ChamS , BasireM , KellyA‐M . Intermediate dose metoclopramide is not more effective than standard dose metoclopramide for patients who present to the emergency department with nausea and vomiting: a pilot study. Emergency Medicine Australasia2004;16(3):208‐11. [PUBMED: 15228463] ">Cham 2004</a>, evaluating a weight‐based dose of metoclopramide with standard dose, reported similar adverse event rates (weight‐based dose: 2/24 (8%); standard dose: 0/34 (0%); P value = 0.33). </p> <p>Adverse events in three of the five trials have previously been described (see 'Comparison of drug versus placebo: Primary outcomes: Adverse reactions'), and there were no differences between metoclopramide and active control (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>). </p> <p><a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a> comparing metoclopramide with tropisetron reported higher rates of akathisia (scored from 0 to 17) in the metoclopramide group at both 30 and 60 minutes (at 30 minutes: MD 1.1, 95% CI 0.1 to 22; at 60 minutes: 1.2, 95% CI 1.01 to 2.5). Baseline akathisia scores were also higher in the metoclopramide group (MD 0.3, 95% CI ‐0.22 to 0.8). Headache was reported by 5/50 (10%) participants in the metoclopramide group and 11/50 (22%) participants in the tropisetron group (difference 12%, 95% CI ‐4.2% to 28.2%, P value = 0.17). Dizziness was reported by 3/50 (6%) participants in the metoclopramide group and 5/50 (10%) participants in the tropisetron group (difference 4.0%, 95% CI ‐8.6% to 16.6%, P value = 0.71). </p> <p>The only significant result was of more frequent akathisia for metoclopramide in comparison with tropisetron (<a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>). </p> </section> </section> <section id="CD010106-sec-0093"> <h5 class="title">Secondary outcomes</h5> <section id="CD010106-sec-0094"> <h6 class="title">Proportion of participants requiring rescue medication</h6> <p>All five trials reported proportion of participants requiring rescue medication (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>; <a href="./references#CD010106-bbs2-0005" title="ChamS , BasireM , KellyA‐M . Intermediate dose metoclopramide is not more effective than standard dose metoclopramide for patients who present to the emergency department with nausea and vomiting: a pilot study. Emergency Medicine Australasia2004;16(3):208‐11. [PUBMED: 15228463] ">Cham 2004</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>). </p> <p><a href="./references#CD010106-bbs2-0005" title="ChamS , BasireM , KellyA‐M . Intermediate dose metoclopramide is not more effective than standard dose metoclopramide for patients who present to the emergency department with nausea and vomiting: a pilot study. Emergency Medicine Australasia2004;16(3):208‐11. [PUBMED: 15228463] ">Cham 2004</a>, comparing the different doses of metoclopramide, reported no difference in proportions requiring rescue medication (OR 0.83, 95% CI 0.18 to 3.86). </p> <p>Four trials compared metoclopramide with any other active control on the outcome of rescue medication requirement in 469 participants (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>). The pooled results showed no difference in requirement for rescue medication between metoclopramide and any active control (OR 0.61, 95% CI 0.21 to 1.73) (<a href="./references#CD010106-fig-0012" title="">Analysis 3.2</a>). Three trials, involving 353 participants, compared metoclopramide with 5‐HT3 blockers (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>). The pooled results showed no difference in the requirement for rescue medication (OR 0.71, 95% CI 0.20 to 2.50) (<a href="./references#CD010106-fig-0015" title="">Analysis 4.2</a>). However, pooled results from the two trials comparing metoclopramide and ondansetron, involving 253 participants, found that fewer participants receiving metoclopramide required rescue medication (OR 0.39, 95% CI 0.22 to 0.68) (<a href="./references#CD010106-fig-0017" title="">Analysis 5.2</a>) (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>). One study comparing metoclopramide with tropisetron, involving 100 participants, found that more participants receiving metoclopramide required rescue medication (OR 3.16, 95% CI 1.03 to 9.69) (<a href="#CD010106-tbl-0006">Table 5</a>) (<a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>). </p> <p>One trial compared metoclopramide with promethazine with fewer participants requiring rescue medication for metoclopramide (9/43 (22%) with metoclopramide versus 19/45 (44%) with promethazine; OR 0.36, 95% CI 0.14 to 0.93) (<a href="#CD010106-tbl-0007">Table 6</a>) (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>). One trial compared metoclopramide with prochlorperazine or droperidol (<a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>). It found no difference in requirement for rescue medication (1/25 (4%) with metoclopramide versus 6/24 (25%) prochlorperazine; OR 0.13, 95% CI 0.01 to 1.13) (<a href="#CD010106-tbl-0008">Table 7</a>); 1/25 (4%) with metoclopramide versus 1/22 (4.5%) with droperidol; OR 0.88, 95% CI 0.05 to 14.87) (<a href="#CD010106-tbl-0009">Table 8</a>). </p> </section> <section id="CD010106-sec-0095"> <h6 class="title">Proportion of participants who required hospital admission</h6> <p>None of the five trials evaluating metoclopramide reported proportion of participants who required hospital admission (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>; <a href="./references#CD010106-bbs2-0005" title="ChamS , BasireM , KellyA‐M . Intermediate dose metoclopramide is not more effective than standard dose metoclopramide for patients who present to the emergency department with nausea and vomiting: a pilot study. Emergency Medicine Australasia2004;16(3):208‐11. [PUBMED: 15228463] ">Cham 2004</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>). </p> </section> <section id="CD010106-sec-0096"> <h6 class="title">Mean or median emergency department length of stay</h6> <p>None of the five trials evaluating metoclopramide reported mean or median ED length of stay (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>; <a href="./references#CD010106-bbs2-0005" title="ChamS , BasireM , KellyA‐M . Intermediate dose metoclopramide is not more effective than standard dose metoclopramide for patients who present to the emergency department with nausea and vomiting: a pilot study. Emergency Medicine Australasia2004;16(3):208‐11. [PUBMED: 15228463] ">Cham 2004</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>). </p> </section> <section id="CD010106-sec-0097"> <h6 class="title">Participant satisfaction with intervention</h6> <p>Two trials, involving 242 participants, reported participant satisfaction (<a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>). From pooled results, there was no difference in participant satisfaction between metoclopramide and active control (OR 1.24, 95% CI 0.71 to 2.17) (<a href="./references#CD010106-fig-0013" title="">Analysis 3.3</a>). </p> <p><a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a> reported satisfaction as 21/25 (84%) with metoclopramide and 20/24 (83%) with prochlorperazine (OR 1.05, 95% CI 0.23 to 4.78) (<a href="#CD010106-tbl-0008">Table 7</a>) and 20/22 (95%) with droperidol (OR 0.53, 95% CI 0.09 to 3.19) (<a href="#CD010106-tbl-0009">Table 8</a>). </p> <p><a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a> reported satisfaction as 53/86 (61%) with metoclopramide and 46/85 (54.1%) with ondansetron (OR 1.36, 95% CI 0.74 to 2.50) (<a href="#CD010106-tbl-0010">Table 9</a>). </p> <div class="table" id="CD010106-tbl-0010"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">Metoclopramide versus ondansetron</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Statistical method</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect estimate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Participant satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>171</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.36 [0.74, 2.50]</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Data from single trials comparing metoclopramide versus active control.</p> <p>CI: confidence interval.</p> </div> </div> </section> </section> </section> <section id="CD010106-sec-0098"> <h4 class="title">Comparison of 5‐HT3 blockers versus active control</h4> <p>Five studies, involving 583 participants, compared 5‐HT3 blockers against an active control (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>; <a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>; <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>). Four trials evaluated ondansetron (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>; <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>), and one trial evaluated tropisetron (<a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>). </p> <section id="CD010106-sec-0099"> <h5 class="title">Primary outcomes</h5> <section id="CD010106-sec-0100"> <h6 class="title">Severity of nausea</h6> <p>All five trials reported the primary outcome of mean VAS rating change for nausea severity from baseline to 30 minutes (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>; <a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>; <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>). From pooled results, the difference in mean VAS rating change (MD) at 30 minutes between 5‐HT3 blockers and any active control was 2.88 (95% CI ‐2.03 to 6.59) (<a href="#CD010106-fig-0005">Figure 5</a>). The results were not affected by exclusion of the study with high risk of bias (<a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>), or by including studies only evaluating ondansetron (<a href="./references#CD010106-fig-0021" title="">Analysis 7.1</a>). </p> <div class="figure" id="CD010106-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 3 5HT‐3 Antagonists versus active control, outcome: 6.1 Change in nausea severity at 30 minutes." data-id="CD010106-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 3 5HT‐3 Antagonists versus active control, outcome: 6.1 Change in nausea severity at 30 minutes. </p> </div> </div> </div> <p>Three trials, involving 356 participants, compared 5‐HT3 blockers with metoclopramide (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>). From pooled results, the difference in mean VAS rating change (MD) at 30 minutes between metoclopramide and 5‐HT3 antagonist was ‐1.74 (95% CI ‐6.88 to 3.40) (<a href="./references#CD010106-fig-0014" title="">Analysis 4.1</a>). Separately, two trials, involving 256 participants, compared ondansetron with metoclopramide (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>), while the other trial, involving 100 participants, compared tropisetron with metoclopramide (<a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>). From pooled results, the difference in mean VAS rating change (MD) at 30 minutes between metoclopramide and ondansetron was ‐2.00 (95% CI ‐8.30 to 4.29) (<a href="./references#CD010106-fig-0016" title="">Analysis 5.1</a>), while for tropisetron it was ‐1.20 (95% CI ‐10.11 to 7.71) (<a href="#CD010106-tbl-0006">Table 5</a>). </p> <p>Two trials, involving 204 participants, compared ondansetron with promethazine (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>). From pooled results, the difference in mean VAS rating change (MD) at 30 minutes was 3.16 (95% CI ‐4.29 to 10.60) (<a href="./references#CD010106-fig-0024" title="">Analysis 8.1</a>). </p> <p>One trial, involving 64 participants, compared ondansetron with prochlorperazine (<a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>). The difference in mean VAS rating change (MD) at 30 minutes between ondansetron and prochlorperazine was 6.50 (95% CI ‐8.70 to 21.70) (<a href="#CD010106-tbl-0011">Table 10</a>). We deemed this trial at high risk of bias (<a href="#CD010106-sec-0071">Risk of bias in included studies</a>). </p> <div class="table" id="CD010106-tbl-0011"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">Ondansetron versus prochlorperazine</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Statistical methods</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect estimate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change in nausea severity at 30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI [mm])</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.50 [‐8.70, 21.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants requiring rescue medication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.74 [0.63, 52.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants who required hospital admission</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 [0.97, 25.77]</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Data from single trial comparing ondansetron versus prochlorperazine (<a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>). </p> <p>CI: confidence interval.</p> </div> </div> </section> <section id="CD010106-sec-0101"> <h6 class="title">Number of vomiting episodes</h6> <p>Three of the five trials evaluating 5‐HT3 antagonists did not report the number of vomiting episodes within the time frame of interest to this review (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>; <a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>). The related findings from <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a> have been previously described (see 'Comparison of drug versus placebo: Primary outcomes: Number of vomiting episodes'). <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a> reported the proportion of participants vomiting from 0 to 30 minutes and 31 to 60 minutes. This was low for both ondansetron and prochlorperazine (0 to 30 minutes: 2/32 (6%) with ondansetron and 0/32 (0%) with prochlorperazine; 31 to 60 minutes: 0/32 (0%) with ondansetron and 1/32 (3%) with prochlorperazine). </p> </section> <section id="CD010106-sec-0102"> <h6 class="title">Adverse reactions</h6> <p>All five trials reported adverse events (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>; <a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>; <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>); however, variability in reporting precluded meaningful pooling of results. </p> <p>Adverse events from the trials of <a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a> were described in preceding sections (see 'Comparison of drug versus placebo: Primary outcomes: Adverse reactions'). <a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a> reported mean change in anxiety and sedation on a VAS from baseline to 30 minutes. For anxiety, the mean changes for ondansetron and promethazine were ‐13 (SD 27) with ondansetron and ‐14 (SD 26) with promethazine (MD ‐1, 95% CI ‐10 to 10). For sedation, the mean changes were less for ondansetron compared with promethazine (5 (SD 25) with ondansetron versus 19 (SD 30) with promethazine; MD 14, 95% CI 5 to 24). <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a> reported no difference in akathisia rates between ondansetron and prochlorperazine (1/32 (3%) with ondansetron versus 3/32 (9%) with prochlorperazine). Sedation scores were also reported to be similar between groups (no details given), while headache scores were reported to be "significantly lower" (P value &lt; 0.05) for prochlorperazine at all time points, but no data were provided. </p> <p>The result favouring ondansetron over active control was a lower rate of sedation (<a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>). The result favouring an active control over ondansetron was a lower headache score for prochlorperazine (<a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>). </p> </section> </section> <section id="CD010106-sec-0103"> <h5 class="title">Secondary outcomes</h5> <section id="CD010106-sec-0104"> <h6 class="title">Proportion of participants requiring rescue medication</h6> <p>Five trials, involving 582 participants, reported the proportion of participants requiring rescue medication (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>; <a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>; <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>). From pooled results, there was no difference in requirement for rescue medication between 5‐HT3 blockers and any active control (OR 1.47, 95% CI 0.72 to 3.01) (<a href="./references#CD010106-fig-0019" title="">Analysis 6.2</a>). </p> <p>From the four trials, involving 482 participants, which evaluated ondansetron against any active control, the pooled analysis found a higher requirement for rescue medication for ondansetron than for active control (OR 2.00, 95% CI 1.29 to 3.09) (<a href="./references#CD010106-fig-0022" title="">Analysis 7.2</a>) (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>; <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>). This result did not change with exclusion of the study at high risk of bias (<a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>). </p> <p>Three of the trials, involving 353 participants, compared 5‐HT3 blockers with metoclopramide (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>). From pooled results, there was no difference in requirement for rescue medication between metoclopramide and 5‐HT3 blockers (OR 0.71, 95% CI 0.20 to 2.50) (<a href="./references#CD010106-fig-0015" title="">Analysis 4.2</a>). Two of these trials, involving 254 participants, compared ondansetron with metoclopramide (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>). Pooled results showed that more participants in the ondansetron group required rescue medication (OR 0.39, 95% CI 0.22 to 0.68) (<a href="./references#CD010106-fig-0017" title="">Analysis 5.2</a>). </p> <p>Two trials, involving 207 participants, compared ondansetron with promethazine (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>). Pooled results showed no difference in requirement for rescue medication (OR 1.29, 95% CI 0.70 to 2.37) (<a href="./references#CD010106-fig-0025" title="">Analysis 8.2</a>). </p> <p>One trial, involving 64 participants, which compared ondansetron with prochlorperazine, reported no difference in requirement for rescue medication (OR 5.74, 95% CI 0.63 to 52.23) (<a href="#CD010106-tbl-0011">Table 10</a>) (<a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>). </p> <p>Pooled results favoured any active control over ondansetron for requirement for rescue medication (<a href="./references#CD010106-fig-0022" title="">Analysis 7.2</a>). For individual drugs, the only significant result was that favouring metoclopramide over ondansetron (<a href="./references#CD010106-fig-0017" title="">Analysis 5.2</a>). </p> </section> <section id="CD010106-sec-0105"> <h6 class="title">Proportion of participants who required hospital admission</h6> <p>Two trials, involving 184 participants, compared need for admission between 5‐HT3 blockers and active control (<a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>; <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>). Pooled results showed no difference between 5‐HT3 blockers and active control (OR 1.84, 95% CI 0.35 to 9.60) (<a href="./references#CD010106-fig-0020" title="">Analysis 6.3</a>). The result did not change with the exclusion of the trial at high risk of bias (<a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>). Separately, <a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a> reported the admission rates to be 13/60 (22%) with ondansetron versus 14/60 (23%) with promethazine (OR 0.91, 95% CI 0.39 to 2.14) (<a href="#CD010106-tbl-0012">Table 11</a>), while <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a> reported admission rates to be 8/32 (25%) with ondansetron versus 2/32 (6%) with prochlorperazine (OR 5.00, 95% CI 0.97 to 25.77) (<a href="#CD010106-tbl-0011">Table 10</a>). </p> <div class="table" id="CD010106-tbl-0012"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 11.</span> <span class="table-title">Ondansetron versus promethazine</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Statistical methods</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect estimate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants who required hospital admission</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.91 [0.39, 2.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Participant satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.63 [0.76, 9.11]</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Data from single trials comparing ondansetron versus active control.</p> <p>CI: confidence interval.</p> </div> </div> </section> <section id="CD010106-sec-0106"> <h6 class="title">Mean or median emergency department length of stay</h6> <p>None of the trials reported the mean or median ED length of stay (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>; <a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>; <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>). </p> </section> <section id="CD010106-sec-0107"> <h6 class="title">Participant satisfaction with intervention</h6> <p>Two trials, involving 263 participants, reported participant satisfaction with intervention (<a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>). Pooled results showed no difference in satisfaction between ondansetron and any active control (OR 1.23, 95% CI 0.36 to 4.22) (<a href="./references#CD010106-fig-0023" title="">Analysis 7.3</a>). Separately, <a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a> reported satisfaction to be 40/44 (91%) with ondansetron versus 38/48 (79%) with promethazine (OR 2.63, 95% CI 0.76 to 9.11) (<a href="#CD010106-tbl-0012">Table 11</a>), while <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a> reported satisfaction to be 53/86 (61.6%) with metoclopramide versus 46/85 (54.1%) with ondansetron (OR 1.36, 95% CI 0.74 to 2.50) (<a href="#CD010106-tbl-0010">Table 9</a>). </p> </section> </section> </section> <section id="CD010106-sec-0108"> <h4 class="title">Comparison of prochlorperazine versus active control</h4> <p>Three trials, involving 219 participants, evaluated prochlorperazine against an active control (<a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a>; <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>). </p> <section id="CD010106-sec-0109"> <h5 class="title">Primary outcomes</h5> <section id="CD010106-sec-0110"> <h6 class="title">Severity of nausea</h6> <p>Two trials, involving 135 participants, reported the primary outcome of mean VAS rating change for nausea severity from baseline to 30 minutes (<a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>). From pooled results, the difference in mean VAS rating change (MD) at 30 minutes between prochlorperazine and active control was 0.93 (95% CI ‐11.57 to 13.42) (<a href="./references#CD010106-fig-0026" title="">Analysis 9.1</a>). </p> <p>One trial, involving 84 participants, reported median VAS rating change at 30 and 60 minutes (<a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a>). These were 45 with prochlorperazine and 27 with promethazine at 30 minutes, and 60.5 with prochlorperazine and 47 with promethazine at 60 minutes. No variances were reported, but the difference was reported to be statistically significant in favour of prochlorperazine (P value = 0.004 at 30 minutes, and P value &lt; 0.001 at 60 minutes). </p> <p>One trial compared prochlorperazine with droperidol (46 participants), and metoclopramide (49 participants) (<a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>). Results favoured droperidol over prochlorperazine, with a difference in mean VAS rating change (MD) at 30 minutes of 14.00 (95% CI 1.67 to 26.33) (<a href="#CD010106-tbl-0013">Table 12</a>), but there was no difference between metoclopramide and prochlorperazine (MD 0.30, 95% CI ‐13.12 to 13.72) (<a href="#CD010106-tbl-0008">Table 7</a>). </p> <div class="table" id="CD010106-tbl-0013"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 12.</span> <span class="table-title">Prochlorperazine versus droperidol</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Statistical methods</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect estimate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change in nausea severity at 30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI [mm])</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.00 [1.67, 26.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants requiring rescue medication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.91 [0.16, 22.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Participant satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.50 [0.08, 3.05]</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Data from single trials comparing prochlorperazine versus droperidol.</p> <p>CI: confidence interval.</p> </div> </div> <p>One trial, involving 64 participants, compared prochlorperazine with ondansetron (<a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>). The difference in mean VAS rating change (MD) at 30 minutes was 6.50 (95% CI ‐8.70 to 21.70) (<a href="#CD010106-tbl-0011">Table 10</a>). </p> <p>One result favoured prochlorperazine over promethazine (<a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a>). One result favoured droperidol over prochlorperazine (<a href="#CD010106-tbl-0013">Table 12</a>) (<a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>). </p> </section> <section id="CD010106-sec-0111"> <h6 class="title">Number of vomiting episodes</h6> <p>None of the trials evaluating prochlorperazine reported the number of vomiting episodes. The related findings from <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a> have been previously described (see 'Comparison of 5‐HT3 blockers versus active control: Primary outcomes: Number of vomiting episodes'). </p> </section> <section id="CD010106-sec-0112"> <h6 class="title">Adverse reactions</h6> <p>All three trials reported adverse events (<a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a>; <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>); however, variations in reporting precluded pooling of data. There were no serious adverse events in any of the trials. </p> <p>Adverse events from <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a> and <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a> have been described in previous sections (see 'Comparison of 5‐HT3 blockers versus active control: Primary outcomes: Adverse reactions'). <a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a> reported identical akathisia rates at 6/42 (14%) with prochlorperazine and promethazine, and drowsiness at 38% with prochlorperazine and 71% with promethazine (difference 33%, 95% CI 13% to 53%; P value = 0.02). </p> <p>The significant result was of a lower rate of drowsiness for prochlorperazine compared with promethazine (<a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a>). </p> </section> </section> <section id="CD010106-sec-0113"> <h5 class="title">Secondary outcomes</h5> <section id="CD010106-sec-0114"> <h6 class="title">Proportion of participants requiring rescue medication</h6> <p>All three trials, involving 219 participants, reported proportion of participants requiring rescue medication (<a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a>; <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>). From pooled results, there was no difference between prochlorperazine and active control (OR 0.77, 95% CI 0.07 to 8.74) (<a href="./references#CD010106-fig-0027" title="">Analysis 9.2</a>). Exclusion of results from the trial at high risk of bias did not change the result (<a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>). </p> <p><a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a> reported requirement for rescue medication in 1/25 (4%) with metoclopramide compared with 6/24 (25%) with prochlorperazine (OR 0.13, 95% CI 0.01, 1.13) (<a href="#CD010106-tbl-0008">Table 7</a>), and 1/22 (4%) with droperidol (OR 1.91, 95% CI 0.16 to 22.66) (<a href="#CD010106-tbl-0013">Table 12</a>). <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a> reported requirement for rescue medication in 5/32 (16%) with ondansetron and 1/32 (3%) with prochlorperazine (OR 5.74, 95% CI 0.63 to 52.23) (<a href="#CD010106-tbl-0011">Table 10</a>). <a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a> reported requirement for rescue medication in 3/42 (7%) with prochlorperazine and 12/42 (29%) with promethazine (OR 0.19, 95% CI 0.05 to 0.74) (<a href="#CD010106-tbl-0014">Table 13</a>). </p> <div class="table" id="CD010106-tbl-0014"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 13.</span> <span class="table-title">Prochlorperazine versus promethazine</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Statistical method</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect estimate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants requiring rescue medication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.19 [0.05, 0.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants who required hospital admission</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 [0.01, 8.22]</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Data from single trials comparing prochlorperazine versus promethazine.</p> <p>CI: confidence interval.</p> </div> </div> <p>The only significant result was that fewer participants required rescue medication with prochlorperazine compared with promethazine (<a href="#CD010106-tbl-0014">Table 13</a>) (<a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a>). </p> </section> <section id="CD010106-sec-0115"> <h6 class="title">Proportion of participants who required hospital admission</h6> <p>Two trials, involving 148 participants, reported proportion of participants who required hospital admission (<a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a>; <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>). From pooled results, the difference favoured prochlorperazine versus active control (OR 0.22, 95% CI 0.05 to 0.95) (<a href="./references#CD010106-fig-0028" title="">Analysis 9.3</a>). Exclusion of the trial at high risk of bias did change the result (<a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>), since <a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a> reported the difference in proportions requiring admission as OR 0.33 (95% CI 0.01 to 8.22) (<a href="#CD010106-tbl-0014">Table 13</a>). </p> </section> <section id="CD010106-sec-0116"> <h6 class="title">Mean or median emergency department length of stay</h6> <p>None of the trials evaluating prochlorperazine reported mean or median ED length of stay (<a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a>; <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>). </p> </section> <section id="CD010106-sec-0117"> <h6 class="title">Participant satisfaction with intervention</h6> <p>Only one trial reported participant satisfaction (<a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>). There was no difference between the groups (20/24 (83%) with prochlorperazine versus 41/47 (87%) with active control; OR 0.73, 95% CI 0.19 to 2.89) (<a href="#CD010106-tbl-0015">Table 14</a>), or separately between prochlorperazine and droperidol (20/24 (83%) with prochlorperazine versus 20/22 (95%) with droperidol; OR 0.50, 95% CI 0.08 to 3.05) (<a href="#CD010106-tbl-0013">Table 12</a>), or prochlorperazine and metoclopramide (20/24 (83%) with prochlorperazine versus 21/25 (84%) with metoclopramide; OR 1.05, 95% CI 0.23 to 4.78) (<a href="#CD010106-tbl-0008">Table 7</a>). </p> <div class="table" id="CD010106-tbl-0015"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 14.</span> <span class="table-title">Prochlorperazine versus active control</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Statistical method</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect estimate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Participant satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.73 [0.19, 2.89]</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Data from single trials comparing prochlorperazine versus active control.</p> <p>CI: confidence interval.</p> </div> </div> </section> </section> </section> <section id="CD010106-sec-0118"> <h4 class="title">Comparison of promethazine versus active control</h4> <p>Three trials, involving 328 participants, evaluated promethazine versus active control (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>; <a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a>). </p> <section id="CD010106-sec-0119"> <h5 class="title">Primary outcomes</h5> <section id="CD010106-sec-0120"> <h6 class="title">Severity of nausea</h6> <p>Two trials, involving 244 participants, reported the primary outcome of mean VAS rating change for nausea severity from baseline to 30 minutes (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>). From pooled results, the difference in mean VAS rating change (MD) at 30 minutes between promethazine and active control was ‐2.17 (95% CI ‐8.99 to 4.66) (<a href="./references#CD010106-fig-0029" title="">Analysis 10.1</a>). </p> <p>One trial, involving 84 participants, reported median VAS rating change at 30 and 60 minutes (<a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a>). These were 45 mm with prochlorperazine and 27 mm with promethazine at 30 minutes, and 60.5 mm with prochlorperazine and 47 mm with promethazine at 60 minutes. No variances were reported, but the difference was reported as being statistically significant in favour of prochlorperazine (P value = 0.004 at 30 minutes, and P value &lt; 0.001 at 60 minutes). </p> <p>Two trials, involving 204 participants, compared promethazine with ondansetron (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>). From pooled results, difference in mean VAS rating change (MD) to 30 minutes between ondansetron and promethazine was 3.16 (95% CI ‐4.29 to 10.60) (<a href="./references#CD010106-fig-0024" title="">Analysis 8.1</a>). </p> <p>One trial, involving 83 participants, compared promethazine with metoclopramide (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>). The difference in mean VAS rating change (MD) at 30 minutes was 0.10 (95% CI ‐10.06 to 10.26) (<a href="#CD010106-tbl-0007">Table 6</a>). </p> <p>The only significant result was that favouring prochlorperazine over promethazine (<a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a>). </p> </section> <section id="CD010106-sec-0121"> <h6 class="title">Number of vomiting episodes</h6> <p>None of the trials reported number of vomiting episodes.</p> </section> <section id="CD010106-sec-0122"> <h6 class="title">Adverse reactions</h6> <p>All three trials reported adverse events, but variable reporting precluded pooling of results (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>; <a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a>). These have been described in detail in previous sections (see 'Comparison of drug versus placebo: Primary outcomes: Adverse reactions' and 'Comparison of prochlorperazine versus active control: Primary outcomes: Adverse reactions'). In brief, <a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a> reported more drowsiness for promethazine versus prochlorperazine (71% with promethazine versus 38% with prochlorperazine; difference 33%, 95% CI 13% to 53%; P value = 0.02), while rates of akathisia were similar at 14% in both groups. <a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a> reported more sedation for promethazine versus ondansetron (difference in mean VAS rating at 30 minutes 14, 95% CI 5 to 24). <a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a> reported no difference in sedation at 30 minutes between promethazine and any active control (OR 1.58, 95% CI 0.74 to 3.34). </p> </section> </section> <section id="CD010106-sec-0123"> <h5 class="title">Secondary outcomes</h5> <section id="CD010106-sec-0124"> <h6 class="title">Proportion of participants requiring rescue medication</h6> <p>Three trials, involving 334 participants, reported proportion of participants requiring rescue medication (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>; <a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a>). From pooled results, there was no difference in need for rescue medication between promethazine and active control (OR 1.55, 95% CI 0.58 to 4.14) (<a href="./references#CD010106-fig-0030" title="">Analysis 10.2</a>). </p> <p>Two trials, involving 207 participants, found no difference between ondansetron and promethazine (OR 1.29, 95% CI 0.70 to 2.37) (<a href="./references#CD010106-fig-0025" title="">Analysis 8.2</a>) (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>). </p> <p>One trial, involving 88 participants, reported less need for rescue medication with metoclopramide versus promethazine (19/43 (22%) with metoclopramide versus 9/45 (44%) with promethazine (OR 0.36, 95% CI 0.14 to 0.93) (<a href="#CD010106-tbl-0007">Table 6</a>) (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>). </p> <p>One trial, involving 84 participants, reported less need for rescue medication with prochlorperazine versus promethazine (3/42 (7%) with prochlorperazine versus 12/42 (29%) with promethazine; OR 0.19, 95% CI 0.05 to 0.74) (<a href="#CD010106-tbl-0014">Table 13</a>) (<a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a>). </p> <p>There was a greater requirement for rescue medication for promethazine in comparison with both metoclopramide (<a href="#CD010106-tbl-0007">Table 6</a>) (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>) and prochlorperazine (<a href="#CD010106-tbl-0014">Table 13</a>) (<a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a>). </p> </section> <section id="CD010106-sec-0125"> <h6 class="title">Proportion of participants who required hospital admission</h6> <p>Two trials, involving 204 participants, reported proportion of participants who required hospital admission (<a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>; <a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a>). From pooled results, there was no difference in admission requirement between promethazine and active control (OR 1.18, 95% CI 0.51 to 2.70) (<a href="./references#CD010106-fig-0031" title="">Analysis 10.3</a>). One trial, involving 120 participants, reported no difference in admission requirement between ondansetron and promethazine (13/60 (22%) with ondansetron versus 14/60 (23%) with promethazine; OR 0.91, 95% CI 0.39 to 2.14) (<a href="#CD010106-tbl-0012">Table 11</a>) (<a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>). One trial, involving 84 participants, reported no difference in admission requirement between prochlorperazine and promethazine (0/42 (0%) with prochlorperazine versus 1/42 (2.4%) with promethazine; OR 0.33, 95% CI 0.01 to 8.22) (<a href="#CD010106-tbl-0014">Table 13</a>) (<a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a>). </p> </section> <section id="CD010106-sec-0126"> <h6 class="title">Mean or median emergency department length of stay</h6> <p>None of the three trials reported mean or median ED length of stay.</p> </section> <section id="CD010106-sec-0127"> <h6 class="title">Participant satisfaction with intervention</h6> <p>One trial, involving 92 participants, reported participant satisfaction with intervention (<a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>). There was no difference between ondansetron and promethazine (40/44 (91%) with ondansetron versus 38/48 (79%) with promethazine; OR 2.63, 95% CI 0.76 to 9.11) (<a href="#CD010106-tbl-0012">Table 11</a>). </p> </section> </section> </section> <section id="CD010106-sec-0128"> <h4 class="title">Comparison of droperidol versus active control</h4> <p>One trial, involving 71 participants, evaluated droperidol against active control (<a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>). </p> <section id="CD010106-sec-0129"> <h5 class="title">Primary outcomes</h5> <section id="CD010106-sec-0130"> <h6 class="title">Severity of nausea</h6> <p><a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a> reported the primary outcome of mean VAS rating change for nausea severity from baseline to 30 minutes. From pooled results, the difference in mean VAS rating change (MD) at 30 minutes between droperidol and active control was ‐14.10 (95% CI ‐24.26 to ‐3.94) (<a href="#CD010106-tbl-0016">Table 15</a>). Separately, the differences in mean VAS rating changes at 30 minutes also favoured droperidol in comparison with metoclopramide (MD 14.30, 95% CI 2.21 to 26.39) (<a href="#CD010106-tbl-0009">Table 8</a>), and with prochlorperazine (MD 14.00, 95% CI 1.67 to 26.33) (<a href="#CD010106-tbl-0013">Table 12</a>). </p> <div class="table" id="CD010106-tbl-0016"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 15.</span> <span class="table-title">Droperidol versus active control</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Statistical method</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect estimate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change in nausea severity at 30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI [mm])</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐14.10 [‐24.26, ‐3.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants requiring rescue medication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.29 [0.03, 2.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Participant satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.41 [0.39, 29.68]</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Data from single trial by <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>. </p> <p>CI: confidence interval.</p> </div> </div> </section> <section id="CD010106-sec-0131"> <h6 class="title">Number of vomiting episodes</h6> <p>The trial did not evaluated number of vomiting episodes.</p> </section> <section id="CD010106-sec-0132"> <h6 class="title">Adverse reactions</h6> <p>Adverse events for this trial have been previously described (see 'Comparison of drug versus placebo: Primary outcomes: Adverse reactions') (<a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>). There were no serious adverse events reported. In brief, the mean changes for anxiety ratings were droperidol ‐25.9 (SD 30.2), metoclopramide ‐25.4 (SD 24.3) and prochlorperazine ‐21.9 (SD 38.8); and for sedation were droperidol 13.5 (SD 32.2), metoclopramide 0.4 (SD 30.1) and prochlorperazine 5.1 (SD 26.5). </p> </section> </section> <section id="CD010106-sec-0133"> <h5 class="title">Secondary outcomes</h5> <section id="CD010106-sec-0134"> <h6 class="title">Proportion of participants requiring rescue medication</h6> <p><a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a> reported requirement for rescue medication, which was similar for droperidol and active control (1/22 (4.5%) with droperidol versus 7/49 (14%) with active control; OR 0.29, 95% CI 0.03 to 2.48) (<a href="#CD010106-tbl-0016">Table 15</a>). Separately, 1/22 (4.5%) with droperidol was compared with the 1/25 (4%) with metoclopramide (OR 0.88, 95% CI 0.05 to 14.87) (<a href="#CD010106-tbl-0009">Table 8</a>) and 6/24 (25%) with prochlorperazine (OR 1.91, 95% CI 0.16 to 22.66) (<a href="#CD010106-tbl-0013">Table 12</a>). </p> </section> <section id="CD010106-sec-0135"> <h6 class="title">Proportion of participants who required hospital admission</h6> <p>The trial did not report proportion of participants who required hospital admission.</p> </section> <section id="CD010106-sec-0136"> <h6 class="title">Mean or median emergency department length of stay</h6> <p>The trial did not report mean or median ED length of stay.</p> </section> <section id="CD010106-sec-0137"> <h6 class="title">Participant satisfaction with intervention</h6> <p>The trial reported participant satisfaction with intervention (<a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>). From pooled results, this was similar between droperidol and active control (20/21 (95%) with droperidol versus 41/48 (85%) with active control; OR 3.41, 95% CI 0.39 to 29.68) (<a href="#CD010106-tbl-0016">Table 15</a>). Separately, the 20/21 (95%) with droperidol was compared with 21/25 (84%) with metoclopramide (OR 0.53, 95% CI 0.09 to 3.19) (<a href="#CD010106-tbl-0009">Table 8</a>) and 20/24 (83%) with prochlorperazine (OR 0.50, 95% CI 0.08 to 3.05) (<a href="#CD010106-tbl-0013">Table 12</a>). </p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010106-sec-0138" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010106-sec-0138">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010106-sec-0180">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010106-sec-0138"></div> <section id="CD010106-sec-0139"> <h3 class="title" id="CD010106-sec-0139">Summary of main results</h3> <p>Nausea and vomiting are frequently present in people in the ED with many different conditions. Early antiemetic drug use is common, regardless of the underlying cause, due to the distressing nature of the symptoms, and the potential for secondary complications. However, despite the frequency of the clinical problem, the limited number of studies eligible for inclusion in this systematic review was surprising. This limited the potential for pooling of results and consideration of potential confounding factors, such as primary diagnostic groups or amount of intravenous fluid administered was not possible. </p> <p>Accepting these limitations, this Cochrane review found no convincing evidence that any one drug had a more clinically significant effect than any other drug, or that any one of a number of drugs was superior to placebo. The three trials with a placebo arm, both individually and with pooling of results where possible, found that there was no significant difference in the VAS reductions between placebo and metoclopramide, ondansetron, prochlorperazine or promethazine (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>). For individual drugs versus any other drug (active control), where results could be pooled from three trials, together with the other four studies that compared different antiemetic drugs (<a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>; <a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>; <a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a>; <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>), differences in VAS reductions between groups were not significant. </p> <p>Only two trials made conclusions of superiority for a particular drug (<a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a>). <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a> reported that the VAS reduction for droperidol was significantly greater than that for each of metoclopramide, prochlorperazine and placebo, and <a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a> concluded that the VAS reduction for prochlorperazine was significantly greater than that for promethazine, but since the reductions in all groups exceeded the MCSD, the clinical significance of this superiority is uncertain. Similarly, two of the trials that included a placebo arm reported a statistically non‐significant trend towards superiority for ondansetron, metoclopramide and promethazine in comparison with placebo (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>), but in both these trials the lower limit of the 95% CI of the VAS reduction for placebo still exceeded the MCSD, so again, the clinical significance of these statistical trends is also doubtful. Although it may seem intuitive that statistically greater reductions would equate with greater clinical benefits, there is no literature to date that supports this notion. </p> <p>Reduction in number of post‐treatment vomiting episodes is used in other settings (<a href="./references#CD010106-bbs2-0021" title="CarlisleJ , StevensonCA . Drugs for preventing postoperative nausea and vomiting. Cochrane Database of Systematic Reviews2006, Issue 3. [DOI: 10.1002/14651858.CD004125.pub2] ">Carlisle 2006</a>), as a primary outcome measure, and so we included it in this review. It proved not be a useful measure, as the majority of participants included in the ED‐based trials had nausea only, and in the three trials that reported number of vomits (<a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>; <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>), frequency was so low that demonstration of a significant reduction within a 30‐minute period was impossible. </p> <p>The final primary outcome measure of adverse events showed variable results, but overall these were fairly mild and did not require specific therapies. There were no serious adverse events in any of the included trials. Promethazine was associated with more sedation or drowsiness in two trials (<a href="./references#CD010106-bbs2-0003" title="BraudeD , CrandallC . Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double‐blind, noninferiority trial. Academic Emergency Medicine2008;15(3):209‐15. [PUBMED: 18304050] ">Braude 2008</a>; <a href="./references#CD010106-bbs2-0007" title="ErnstA , WeissS , ParkS , TakakuwaK , DiercksD . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double‐blind clinical trial. Annals of Emergency Medicine2000;36(2):89‐94. [PUBMED: 10918098] ">Ernst 2000</a>), ondansetron with headaches (<a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>), and metoclopramide and prochlorperazine with some akathisia (<a href="./references#CD010106-bbs2-0004" title="ChaeJ , TaylorDM , FraumanAG . Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: a randomized, double‐blind, clinical trial. Emergency Medicine Australasia2011;23(5):554‐61. [PUBMED: 21995469] ">Chae 2011</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>; <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>), although these effects were relatively unusual and mild. One large systematic review on drugs for preventing postoperative nausea and vomiting reported on adverse effects from 380 trials finding droperidol increased the risk of drowsiness, while decreasing the risk of headache, and ondansetron increased the risk of headache but found no evidence for a difference in risk in other adverse effects (<a href="./references#CD010106-bbs2-0021" title="CarlisleJ , StevensonCA . Drugs for preventing postoperative nausea and vomiting. Cochrane Database of Systematic Reviews2006, Issue 3. [DOI: 10.1002/14651858.CD004125.pub2] ">Carlisle 2006</a>). </p> <p>Of the secondary outcome measures under consideration, only dispensing of additional rescue medication was included in all trials. The small number of trials, along with variable and inconsistent results, meant that this was of limited utility. This may stem from a lack of definition as to what constituted a need for rescue medication, as in all studies this was at the discretion of the treating ED doctor. Of note, treatment with promethazine was associated with higher requirement for rescue medication, and interestingly participants treated with ondansetron were more likely to require rescue medication compared to either active control or metoclopramide. Few trials reported participant satisfaction or hospital admission rates, with hospital admission rates not being included in any of the trials with placebo control. Participant satisfaction was similar with all drugs included in the review. None of the trials reported ED lengths of stay. It is noteworthy that we did not demonstrate the superiority of 5HT3 antagonists compared to other classes for any of the outcomes assessed, and perhaps contrary to the common anecdotal perception of effectiveness. </p> </section> <section id="CD010106-sec-0140"> <h3 class="title" id="CD010106-sec-0140">Overall completeness and applicability of evidence</h3> <p>Overall, there was a paucity of clinical trials assessing the effectiveness of antiemetic medications for nausea and vomiting in the ED setting. In total, fewer than 1000 participants have been evaluated in this setting. This is somewhat surprising, given the frequency of the symptom in EDs, and although treatment of the condition with antiemetics in clinical practice is very common, there is little consensus on the most appropriate treatment. Interpretation of the available evidence is hampered by clinical heterogeneity, specifically the variety of different drugs evaluated in studies to date, difference in baseline severity and inclusion criteria, and the wide variety of underlying illnesses leading to the symptom of nausea in the ED setting. Most of the trials included in this Cochrane review did have fairly broad inclusion criteria, so while general conclusions could be drawn, the applicability of the findings to all people with nausea in the ED, or to particular subsets of them, remains uncertain. Given the relative paucity of trials in the ED setting, in certain circumstances it may be appropriate to extrapolate evidence from systematic reviews in other settings (e.g. nausea and vomiting in early pregnancy) (<a href="./references#CD010106-bbs2-0035" title="MathewsA , DowswellT , HassDM , DoyleM , O'MathunaDP . Interventions for nausea and vomiting in early pregnancy. Cochrane Database of Systematic Reviews2010, Issue 9. [DOI: 10.1002/14651858.CD007575.pub2] ">Mathews 2010</a>). The drugs evaluated in the eight included trials mirrored common practice, with metoclopramide being included in five trials, 5‐HT3 antagonists in four, promethazine in three, prochlorperazine in two and droperidol in one, but there are other agents and the use of drugs in combination was not studied. </p> <p>The use of change in the VAS, on which the conclusions of this review are primarily based, could also be debated. The VAS, for measurement and monitoring of change in nausea severity, has been validated. High correlation between adjectival descriptors of severity and VAS measurement ranges has been demonstrated, and the MCSD has been defined as the mean VAS change when people report symptom severity as being "a little less". Research on the MCSD is somewhat limited, however, but it appears that the MCSD is greater for people whose baseline nausea is severe, than for people with moderate or mild severity. Hence, reported figures have ranged between 12 and 30 mm, seemingly dependent on the severity mix of the particular population. In this review, we noted that while differences in VAS reductions between groups were similar, the VAS reductions reported for the same drugs in different studies varied quite widely. It was generally the case that when baseline VAS ratings were higher, the reported post‐treatment reductions, including for placebo where included, were greater. This finding seems consistent with reports of variability in the MCSD for different severity subgroups, and highlights the difficulty of pre‐defining a single MCSD for multiple populations. We did nominate a mid‐range MCSD of 15 mm for use in this review, which is obviously problematic, but since VAS reductions for all treatments in all studies comfortably exceeded this figure, it seems reasonable to conclude that the reported levels of participant improvement were clinically significant. </p> </section> <section id="CD010106-sec-0141"> <h3 class="title" id="CD010106-sec-0141">Quality of the evidence</h3> <p>The methodology of the trials included in the review appeared to be adequate overall, and are reported further in the <a href="#CD010106-sec-0050">Assessment of risk of bias in included studies</a> section. We judged two trials to have a high risk of bias because they were inadequately blinded or did not report adequately on certain domains that we were unable to clarify with authors (<a href="./references#CD010106-bbs2-0005" title="ChamS , BasireM , KellyA‐M . Intermediate dose metoclopramide is not more effective than standard dose metoclopramide for patients who present to the emergency department with nausea and vomiting: a pilot study. Emergency Medicine Australasia2004;16(3):208‐11. [PUBMED: 15228463] ">Cham 2004</a>; <a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>). We judged the remaining included trials to be low risk of bias overall, although some minor methodological issues remained. </p> </section> <section id="CD010106-sec-0142"> <h3 class="title" id="CD010106-sec-0142">Potential biases in the review process</h3> <p>Potential biases were minimized by performing a comprehensive search for potentially eligible studies. We were unable to obtain trial reports, or sufficient data on four unpublished studies identified through searching clinical trial registries, which may introduce some possibility of bias (<a href="./references#CD010106-bbs2-0014" title="FriedlandH , DavidS , RenaeB , AmitS , LatisseM , MonicaS , et al. A randomized trial comparing the efficacy of low dose iv granisetron (0.1mg) versus iv prochlorperazine (10mg) in the treatment of acute nausea and vomiting. Proceedings of the Annual Meeting of the Society for Academic Emergency Medicine (SAEM); 2008 May 29‐June 1; Washington. Washington: Academic Emergency Medicine, 2008. ">Friedland 2008</a>; <a href="./references#CD010106-bbs2-0015" title="HaenselC , SmithD , PollackM , OwensL . Ondansetron versus metoclopramide for nausea and vomiting in the emergency department. Proceedings of the Annual Meeting of the Society for Academic Emergency Medicine; 2007 May 16‐19; Chicago. Chicago: Academic Emergency Medicine, 2007. ">Haensel 2007</a>; <a href="./references#CD010106-bbs2-0016" title="ThackerJ , MinerJ , BirosM . Droperidol versus metoclopramide for the treatment of nausea. Proceedings of the American College of Emergency Physicians; 2003 Oct 12‐13; Boston. Boston: American College of Emergency Physicians, 2003. ">Thacker 2003</a>; <a href="./references#CD010106-bbs2-0017" title="ThackerJ , MinerJ . Droperidol dosing for nausea and vomiting. Proceedings of the American College of Emergency Physicians; 2004 Oct 16‐18; San Francisco. San Francisco: American College of Emergency Physicians, 2004. ">Thacker 2004</a>). </p> <p>Clinical heterogeneity between trials made pooling of data for meta‐analysis difficult for some outcomes. The clinical heterogeneity consisted of included trials evaluating different agents, different doses, and using different active control groups and only three trials including a placebo control arm (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>; <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>; <a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>). Results and analysis of random‐effects model analysis were presented for outcomes comparing both individual drugs and combined with active controls. Comprehensive data comparing various doses of drugs included in the review were lacking, and we thought this unlikely to affect the results substantially. We believe the comparisons presented here to be valid and informative. </p> <p>Two authors of this review were also authors of one of the included studies (<a href="./references#CD010106-bbs2-0006" title="Egerton‐WarburtonD , MeekR , MeeMJ , BraitbergG . Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide and placebo. Annals of Emergency Medicine2014;64(5):526‐32. [DOI: 10.1016/j.annemergmed.2014.03.017; PUBMED: 24818542] ">Egerton‐Warburton 2014</a>). We minimized bias as data extraction and assessment of quality was conducted by an author not involved with the study (JF). There were no disagreements with this trial in assessment of quality or data extraction, and as such did not require arbitration with an independent person. </p> </section> <section id="CD010106-sec-0143"> <h3 class="title" id="CD010106-sec-0143">Agreements and disagreements with other studies or reviews</h3> <p>We are not aware of any previous systematic reviews on the treatment of nausea and vomiting in the ED setting. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010106-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/urn:x-wiley:14651858:media:CD010106:CD010106-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_t/tCD010106-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD010106-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/full#CD010106-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010106-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/urn:x-wiley:14651858:media:CD010106:CD010106-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_t/tCD010106-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010106-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/full#CD010106-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010106-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/urn:x-wiley:14651858:media:CD010106:CD010106-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_t/tCD010106-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010106-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/full#CD010106-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010106-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/urn:x-wiley:14651858:media:CD010106:CD010106-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_t/tCD010106-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Metoclopramide versus placebo, outcome: 1.1 Change in nausea severity at 30 minutes." data-id="CD010106-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Metoclopramide versus placebo, outcome: 1.1 Change in nausea severity at 30 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/full#CD010106-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010106-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/urn:x-wiley:14651858:media:CD010106:CD010106-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_t/tCD010106-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 3 5HT‐3 Antagonists versus active control, outcome: 6.1 Change in nausea severity at 30 minutes." data-id="CD010106-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 3 5HT‐3 Antagonists versus active control, outcome: 6.1 Change in nausea severity at 30 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/full#CD010106-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010106-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/urn:x-wiley:14651858:media:CD010106:CD010106-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_t/tCD010106-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Metoclopramide versus placebo, Outcome 1 Change in nausea severity at 30 minutes." data-id="CD010106-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Metoclopramide versus placebo, Outcome 1 Change in nausea severity at 30 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010106-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/urn:x-wiley:14651858:media:CD010106:CD010106-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_t/tCD010106-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Metoclopramide versus placebo, Outcome 2 Proportion of participants requiring rescue medication." data-id="CD010106-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Metoclopramide versus placebo, Outcome 2 Proportion of participants requiring rescue medication. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010106-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/urn:x-wiley:14651858:media:CD010106:CD010106-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_t/tCD010106-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Metoclopramide versus placebo, Outcome 3 Participant satisfaction." data-id="CD010106-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Metoclopramide versus placebo, Outcome 3 Participant satisfaction.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010106-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/urn:x-wiley:14651858:media:CD010106:CD010106-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_t/tCD010106-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Ondansetron versus placebo, Outcome 1 Change in nausea severity at 30 minutes." data-id="CD010106-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Ondansetron versus placebo, Outcome 1 Change in nausea severity at 30 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010106-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/urn:x-wiley:14651858:media:CD010106:CD010106-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_t/tCD010106-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Ondansetron versus placebo, Outcome 2 Proportion of participants requiring rescue medication." data-id="CD010106-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Ondansetron versus placebo, Outcome 2 Proportion of participants requiring rescue medication. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010106-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/urn:x-wiley:14651858:media:CD010106:CD010106-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_t/tCD010106-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Metoclopramide versus active control, Outcome 1 Change in nausea severity at 30 minutes." data-id="CD010106-fig-0011" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Metoclopramide versus active control, Outcome 1 Change in nausea severity at 30 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010106-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/urn:x-wiley:14651858:media:CD010106:CD010106-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_t/tCD010106-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Metoclopramide versus active control, Outcome 2 Proportion of participants requiring rescue medication." data-id="CD010106-fig-0012" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Metoclopramide versus active control, Outcome 2 Proportion of participants requiring rescue medication. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010106-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/urn:x-wiley:14651858:media:CD010106:CD010106-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_t/tCD010106-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Metoclopramide versus active control, Outcome 3 Participant satisfaction." data-id="CD010106-fig-0013" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Metoclopramide versus active control, Outcome 3 Participant satisfaction.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010106-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/urn:x-wiley:14651858:media:CD010106:CD010106-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_t/tCD010106-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Metoclopramide versus 5HT3 antagonist, Outcome 1 Change in nausea severity at 30 minutes." data-id="CD010106-fig-0014" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Metoclopramide versus 5HT3 antagonist, Outcome 1 Change in nausea severity at 30 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010106-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/urn:x-wiley:14651858:media:CD010106:CD010106-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_t/tCD010106-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Metoclopramide versus 5HT3 antagonist, Outcome 2 Proportion of participants requiring rescue medication." data-id="CD010106-fig-0015" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Metoclopramide versus 5HT3 antagonist, Outcome 2 Proportion of participants requiring rescue medication. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010106-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/urn:x-wiley:14651858:media:CD010106:CD010106-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_t/tCD010106-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Metoclopramide versus ondansetron, Outcome 1 Change in nausea severity at 30 minutes." data-id="CD010106-fig-0016" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Metoclopramide versus ondansetron, Outcome 1 Change in nausea severity at 30 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010106-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/urn:x-wiley:14651858:media:CD010106:CD010106-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_t/tCD010106-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Metoclopramide versus ondansetron, Outcome 2 Proportion of participants requiring rescue medication." data-id="CD010106-fig-0017" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Metoclopramide versus ondansetron, Outcome 2 Proportion of participants requiring rescue medication. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010106-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/urn:x-wiley:14651858:media:CD010106:CD010106-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_t/tCD010106-CMP-006-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 5HT3 Antagonists versus active control, Outcome 1 Change in nausea severity at 30 minutes." data-id="CD010106-fig-0018" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 5HT3 Antagonists versus active control, Outcome 1 Change in nausea severity at 30 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010106-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/urn:x-wiley:14651858:media:CD010106:CD010106-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_t/tCD010106-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 5HT3 Antagonists versus active control, Outcome 2 Proportion of participants requiring rescue medication." data-id="CD010106-fig-0019" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 5HT3 Antagonists versus active control, Outcome 2 Proportion of participants requiring rescue medication. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010106-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/urn:x-wiley:14651858:media:CD010106:CD010106-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_t/tCD010106-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 5HT3 Antagonists versus active control, Outcome 3 Proportion of participants who required hospital admission." data-id="CD010106-fig-0020" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 5HT3 Antagonists versus active control, Outcome 3 Proportion of participants who required hospital admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010106-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/urn:x-wiley:14651858:media:CD010106:CD010106-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_t/tCD010106-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Ondansetron versus active control, Outcome 1 Change in nausea severity at 30 minutes." data-id="CD010106-fig-0021" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Ondansetron versus active control, Outcome 1 Change in nausea severity at 30 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010106-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/urn:x-wiley:14651858:media:CD010106:CD010106-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_t/tCD010106-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Ondansetron versus active control, Outcome 2 Proportion of participants requiring rescue medication." data-id="CD010106-fig-0022" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Ondansetron versus active control, Outcome 2 Proportion of participants requiring rescue medication. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010106-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/urn:x-wiley:14651858:media:CD010106:CD010106-CMP-007-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_t/tCD010106-CMP-007-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Ondansetron versus active control, Outcome 3 Participant satisfaction." data-id="CD010106-fig-0023" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-007-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 Ondansetron versus active control, Outcome 3 Participant satisfaction.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-007-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010106-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/urn:x-wiley:14651858:media:CD010106:CD010106-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_t/tCD010106-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Ondansetron versus promethazine, Outcome 1 Change in nausea severity at 30 minutes." data-id="CD010106-fig-0024" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 Ondansetron versus promethazine, Outcome 1 Change in nausea severity at 30 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010106-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/urn:x-wiley:14651858:media:CD010106:CD010106-CMP-008-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_t/tCD010106-CMP-008-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Ondansetron versus promethazine, Outcome 2 Proportion of participants requiring rescue medication." data-id="CD010106-fig-0025" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-008-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8 Ondansetron versus promethazine, Outcome 2 Proportion of participants requiring rescue medication. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-008-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010106-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/urn:x-wiley:14651858:media:CD010106:CD010106-CMP-009-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_t/tCD010106-CMP-009-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Prochlorperazine versus active control, Outcome 1 Change in nausea severity at 30 minutes." data-id="CD010106-fig-0026" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-009-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9 Prochlorperazine versus active control, Outcome 1 Change in nausea severity at 30 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-009-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010106-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/urn:x-wiley:14651858:media:CD010106:CD010106-CMP-009-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_t/tCD010106-CMP-009-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Prochlorperazine versus active control, Outcome 2 Proportion of participants requiring rescue medication." data-id="CD010106-fig-0027" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-009-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9 Prochlorperazine versus active control, Outcome 2 Proportion of participants requiring rescue medication. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-009-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010106-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/urn:x-wiley:14651858:media:CD010106:CD010106-CMP-009-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_t/tCD010106-CMP-009-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Prochlorperazine versus active control, Outcome 3 Proportion of participants who required hospital admission." data-id="CD010106-fig-0028" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-009-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.3</div> <div class="figure-caption"> <p>Comparison 9 Prochlorperazine versus active control, Outcome 3 Proportion of participants who required hospital admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-009-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010106-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/urn:x-wiley:14651858:media:CD010106:CD010106-CMP-010-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_t/tCD010106-CMP-010-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Promethazine versus active control, Outcome 1 Change in nausea severity at 30 minutes." data-id="CD010106-fig-0029" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-010-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10 Promethazine versus active control, Outcome 1 Change in nausea severity at 30 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-010-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010106-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/urn:x-wiley:14651858:media:CD010106:CD010106-CMP-010-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_t/tCD010106-CMP-010-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Promethazine versus active control, Outcome 2 Proportion of participants requiring rescue medication." data-id="CD010106-fig-0030" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-010-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.2</div> <div class="figure-caption"> <p>Comparison 10 Promethazine versus active control, Outcome 2 Proportion of participants requiring rescue medication. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-010-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010106-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/urn:x-wiley:14651858:media:CD010106:CD010106-CMP-010-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_t/tCD010106-CMP-010-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Promethazine versus active control, Outcome 3 Proportion of participants who required hospital admission." data-id="CD010106-fig-0031" src="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-010-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.3</div> <div class="figure-caption"> <p>Comparison 10 Promethazine versus active control, Outcome 3 Proportion of participants who required hospital admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/media/CDSR/CD010106/image_n/nCD010106-CMP-010-03.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010106-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Metoclopramide for nausea and vomiting in the emergency department</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Metoclopramide for nausea and vomiting in the emergency department</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with nausea and vomiting </p> <p><b>Settings:</b> emergency department<br/> <b>Intervention:</b> metoclopramide </p> <p><b>Comparisons:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Metoclopramide</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in nausea severity at 30 minutes</b><br/> Visual analogue scale Scale from: 0 to 100<br/> Follow‐up: 30 minutes </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean nausea severity decrease ‐ metoclopramide vs. placebo ranged across control groups from<br/> <b>23 to 38 mm</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean nausea severity decrease ‐ metoclopramide vs. placebo in the intervention groups was<br/> <b>5.27 lower</b><br/> (11.33 lower to 0.8 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>301<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> low<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A larger decrease in nausea severity score indicates better control of symptoms. A difference of &gt; 15 mm is thought to be the 'minimum clinically significant difference' </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of vomiting episodes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>301</p> <p>(3 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>This outcome was not reported in any of the included studies</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse reactions</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>301</p> <p>(3 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No pooling of results was possible, due to variations in reporting. No studies reported any serious adverse reactions or significant difference in adverse reactions </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Proportion of participants requiring rescue medication</b> <br/> Physician's discretion<br/> Follow‐up: 60 minutes </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 0.3</b> <br/> (0.17 to 0.53) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>299<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> low<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>An OR &lt; 1 means less need for the medication with metoclopramide</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>381 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>156 per 1000</b><br/> (95 to 246) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>363 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>146 per 1000</b><br/> (88 to 232) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Participant satisfaction with intervention</b><br/> Self report </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 1.07</b> <br/> (0.6 to 1.91) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>216<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> low<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>An OR &lt; 1 implies better satisfaction with metoclopramide</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>657 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>672 per 1000</b><br/> (535 to 785) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>721 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>734 per 1000</b><br/> (608 to 832) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>OR:</b> odds ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded for imprecision (wide confidence interval and not achieving optimal information size).<br/> <sup>2</sup> Downgraded as this outcome was poorly described and variable in the included trials and imprecision. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Metoclopramide for nausea and vomiting in the emergency department</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/full#CD010106-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010106-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Prochlorperazine versus placebo</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Statistical methods</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect estimate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change in nausea severity at 30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI [mm])</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.80 [‐14.40, 10.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants requiring rescue medication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.83 [0.45, 7.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Participant satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.91 [0.20, 4.13]</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>Data from single trial comparing prochlorperazine versus placebo (<a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>). </p> <p>CI: confidence interval.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Prochlorperazine versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/full#CD010106-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010106-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Promethazine versus placebo</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Statistical methods</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect estimate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change in nausea severity at 30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI [mm])</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐8.47 [‐19.79, 2.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants requiring rescue medication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.57 [0.24, 1.34]</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>Data from single trial comparing promethazine versus placebo (<a href="./references#CD010106-bbs2-0001" title="BarrettT , DipersioD , JenkinsC , JackM , McCoinN , StorrowA . A randomized, placebo‐controlled trial of ondansetron, metoclopramide, and promethazine in adults. American Journal of Emergency Medicine2011;29(3):247‐55. [PUBMED: 20825792] ">Barrett 2011</a>). </p> <p>CI: confidence interval.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Promethazine versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/full#CD010106-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010106-tbl-0004"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Droperidol versus placebo</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Statistical methods</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect estimate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change in nausea severity at 30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI [mm])</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐15.80 [‐26.98, ‐4.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants requiring rescue medication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.26 [0.03, 2.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Participant satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.82 [0.30, 11.02]</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>Data from single trial comparing droperidol versus placebo (<a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>). </p> <p>CI: confidence interval.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Droperidol versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/full#CD010106-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010106-tbl-0005"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Ondansetron versus placebo</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Statistical methods</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect estimate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Participant satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>164</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.80 [0.43, 1.49]</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>Data from single trials comparing drug versus placebo.</p> <p>CI: confidence interval.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Ondansetron versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/full#CD010106-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010106-tbl-0006"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Metoclopramide versus tropisetron</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Statistical method</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect estimate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change in nausea severity at 30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI [mm])</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.20 [‐10.11, 7.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants requiring rescue medication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.16 [1.03, 9.69]</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>Data from single trials comparing metoclopramide versus active control.</p> <p>CI: confidence interval.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Metoclopramide versus tropisetron</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/full#CD010106-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010106-tbl-0007"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Metoclopramide versus promethazine</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Statistical method</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect estimate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change in nausea severity at 30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI [mm])</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.10 [‐10.06, 10.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants requiring rescue medication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.36 [0.14, 0.93]</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>Data from single trials comparing metoclopramide versus active control.</p> <p>CI: confidence interval.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Metoclopramide versus promethazine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/full#CD010106-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010106-tbl-0008"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Metoclopramide versus prochlorperazine</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Statistical method</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect estimate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change in nausea severity at 30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI [mm])</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.30 [‐13.12, 13.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants requiring rescue medication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.13 [0.01, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Participant satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.05 [0.23, 4.78]</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>Data from single trials comparing metoclopramide versus active control.</p> <p>CI: confidence interval.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Metoclopramide versus prochlorperazine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/full#CD010106-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010106-tbl-0009"> <div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Metoclopramide versus droperidol</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Statistical method</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect estimate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change in nausea severity at 30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI [mm])</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.30 [2.21, 26.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants requiring rescue medication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.88 [0.05, 14.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Participant satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.53 [0.09, 3.19]</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>Data from single trials comparing metoclopramide versus active control.</p> <p>CI: confidence interval.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Metoclopramide versus droperidol</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/full#CD010106-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010106-tbl-0010"> <div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">Metoclopramide versus ondansetron</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Statistical method</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect estimate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Participant satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>171</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.36 [0.74, 2.50]</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>Data from single trials comparing metoclopramide versus active control.</p> <p>CI: confidence interval.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">Metoclopramide versus ondansetron</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/full#CD010106-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010106-tbl-0011"> <div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">Ondansetron versus prochlorperazine</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Statistical methods</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect estimate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change in nausea severity at 30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI [mm])</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.50 [‐8.70, 21.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants requiring rescue medication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.74 [0.63, 52.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants who required hospital admission</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 [0.97, 25.77]</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>Data from single trial comparing ondansetron versus prochlorperazine (<a href="./references#CD010106-bbs2-0008" title="PatkaJ , WuDT , AbrahamP , SobelR . Randomized controlled trial of ondansetron vs prochlorperazine in adults in the emergency department. Western Journal of Emergency Medicine2011;12(1):1‐5. [PUBMED: 21691464] ">Patka 2011</a>). </p> <p>CI: confidence interval.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">Ondansetron versus prochlorperazine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/full#CD010106-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010106-tbl-0012"> <div class="table-heading"><span class="table-label">Table 11.</span> <span class="table-title">Ondansetron versus promethazine</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Statistical methods</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect estimate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants who required hospital admission</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.91 [0.39, 2.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Participant satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.63 [0.76, 9.11]</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>Data from single trials comparing ondansetron versus active control.</p> <p>CI: confidence interval.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 11.</span> <span class="table-title">Ondansetron versus promethazine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/full#CD010106-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010106-tbl-0013"> <div class="table-heading"><span class="table-label">Table 12.</span> <span class="table-title">Prochlorperazine versus droperidol</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Statistical methods</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect estimate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change in nausea severity at 30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI [mm])</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.00 [1.67, 26.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants requiring rescue medication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.91 [0.16, 22.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Participant satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.50 [0.08, 3.05]</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>Data from single trials comparing prochlorperazine versus droperidol.</p> <p>CI: confidence interval.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 12.</span> <span class="table-title">Prochlorperazine versus droperidol</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/full#CD010106-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010106-tbl-0014"> <div class="table-heading"><span class="table-label">Table 13.</span> <span class="table-title">Prochlorperazine versus promethazine</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Statistical method</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect estimate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants requiring rescue medication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.19 [0.05, 0.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants who required hospital admission</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 [0.01, 8.22]</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>Data from single trials comparing prochlorperazine versus promethazine.</p> <p>CI: confidence interval.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 13.</span> <span class="table-title">Prochlorperazine versus promethazine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/full#CD010106-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010106-tbl-0015"> <div class="table-heading"><span class="table-label">Table 14.</span> <span class="table-title">Prochlorperazine versus active control</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Statistical method</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect estimate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Participant satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.73 [0.19, 2.89]</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>Data from single trials comparing prochlorperazine versus active control.</p> <p>CI: confidence interval.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 14.</span> <span class="table-title">Prochlorperazine versus active control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/full#CD010106-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010106-tbl-0016"> <div class="table-heading"><span class="table-label">Table 15.</span> <span class="table-title">Droperidol versus active control</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Statistical method</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect estimate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change in nausea severity at 30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI [mm])</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐14.10 [‐24.26, ‐3.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants requiring rescue medication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.29 [0.03, 2.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Participant satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.41 [0.39, 29.68]</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>Data from single trial by <a href="./references#CD010106-bbs2-0002" title="BraudeD , SolizT , CrandallC , HendeyG , AndrewsJ , WeichenthalL . Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. American Journal of Emergency Medicine2006;24(2):177‐82. [PUBMED: 16490647] ">Braude 2006</a>. </p> <p>CI: confidence interval.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 15.</span> <span class="table-title">Droperidol versus active control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/full#CD010106-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010106-tbl-0017"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Metoclopramide versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Change in nausea severity at 30 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.27 [‐11.33, 0.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Proportion of participants requiring rescue medication <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>299</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [0.17, 0.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Participant satisfaction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>216</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.60, 1.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Metoclopramide versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-tbl-0017">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010106-tbl-0018"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Ondansetron versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Change in nausea severity at 30 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>250</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.32 [‐11.20, 2.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Proportion of participants requiring rescue medication <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.49, 1.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Ondansetron versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-tbl-0018">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010106-tbl-0019"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Metoclopramide versus active control</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Change in nausea severity at 30 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>470</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.00 [‐4.50, 4.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Proportion of participants requiring rescue medication <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>469</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.21, 1.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Participant satisfaction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>242</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [0.71, 2.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Metoclopramide versus active control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-tbl-0019">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010106-tbl-0020"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Metoclopramide versus 5HT3 antagonist</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Change in nausea severity at 30 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>356</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.74 [‐6.88, 3.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Proportion of participants requiring rescue medication <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>353</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.20, 2.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Metoclopramide versus 5HT3 antagonist</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-tbl-0020">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010106-tbl-0021"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Metoclopramide versus ondansetron</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Change in nausea severity at 30 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.00 [‐8.30, 4.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Proportion of participants requiring rescue medication <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.22, 0.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Metoclopramide versus ondansetron</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-tbl-0021">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010106-tbl-0022"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">5HT3 Antagonists versus active control</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Change in nausea severity at 30 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>583</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.28 [‐2.03, 6.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Proportion of participants requiring rescue medication <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>582</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.47 [0.72, 3.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Proportion of participants who required hospital admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.84 [0.35, 9.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">5HT3 Antagonists versus active control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-tbl-0022">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010106-tbl-0023"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Ondansetron versus active control</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Change in nausea severity at 30 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>483</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.61 [‐2.31, 7.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Proportion of participants requiring rescue medication <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>482</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.00 [1.29, 3.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Participant satisfaction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>263</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.36, 4.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Ondansetron versus active control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-tbl-0023">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010106-tbl-0024"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Ondansetron versus promethazine</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Change in nausea severity at 30 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>204</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.16 [‐4.29, 10.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Proportion of participants requiring rescue medication <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>207</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.70, 2.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Ondansetron versus promethazine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-tbl-0024">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010106-tbl-0025"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Prochlorperazine versus active control</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Change in nausea severity at 30 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>135</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [‐11.57, 13.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Proportion of participants requiring rescue medication <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.07, 8.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Proportion of participants who required hospital admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.05, 0.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Prochlorperazine versus active control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-tbl-0025">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010106-tbl-0026"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Promethazine versus active control</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Change in nausea severity at 30 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>244</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.17 [‐8.99, 4.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Proportion of participants requiring rescue medication <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>334</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.55 [0.58, 4.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Proportion of participants who required hospital admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>204</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.51, 2.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Promethazine versus active control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010106.pub2/references#CD010106-tbl-0026">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010106.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD010106-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010106-note-0024">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD010106-note-0003">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD010106-note-0002">Hrvatski</a> </li> <li class="section-language"> <a class="" href="pt#CD010106-note-0001">Português</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010106\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010106\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010106\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010106\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010106\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010106\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010106\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010106\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010106\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010106\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010106\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010106\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010106\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010106\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010106\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010106\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010106\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010106\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=tkZQC4GK&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010106.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010106.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010106.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010106.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010106.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740716469148"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010106.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740716469152"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010106.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918da0461c399379',t:'MTc0MDcxNjQ2OS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 